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This dissertation focuses on a detailed mechanism of mRNA transport during 
development of hippocampal neurons, and regulation of retrograde injury signaling 
(RIS)-associated genes in the context of regeneration.  Damaged neurons in the CNS are 
unable to regenerate leading to neuronal degeneration and cell death.  Identifying 
mechanisms that promote axonal regeneration of the damaged fibers is beneficial.  First, I 
set to explore the detailed quantification of mRNA transport during the development of 
hippocampal neurons. Rigorous quantitative assessment of mRNA transport concluded 
that mRNA transport is driven by the functional demands of the cell.  I measured the 
velocity, directionality and the duration of mRNA particles.  In the axons, net velocity 
was highest at day 7 in vitro, which coincides with the initial stage of synapse formation.  
Within dendrites, it continues to increase through day 12 in vitro coinciding with an 
increased duration of synaptic contact, suggesting role of protein synthesis in context of 
sustained synaptic connectivity.  Next, I set to explore regulations of genes involved in 
RIS process, a process stimulated upon injury and required for axonal regeneration.  
Investigation of regulation of RIS associated axonal transcript levels led to development 
of a whole hippocampal explant culture system.  The hippocampal explant culture system 
enabled examination of axonal gene and protein expression independent of neuronal cell 
bodies.  The study of RIS process suggests a novel biphasic increase in axonal gene 
expression (1 & 24 hrs post-injury).  These genes are tightly and differentially regulated 
contributing to early synthesis of corresponding axonal proteins in hippocampal neurons.  
Additionally, importin β-dependent activity at the nucleus then appears to modulate a 
second wave (24 hrs) of RIS-associated transcripts, which are likely to further support 
axonal outgrowth.  These studies provide insight into a powerful set of axonal processes 
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Chapter 1: Introduction  
Section 1: CNS disorder and Causes 
Diffuse Axonal Injury (DAI) is a severe type of traumatic brain injury (TBI) 
resulting in the tearing of axons and eventually, cognitive dysfunction [3,4].  Brain injury 
occurs when a sudden trauma causes damage to the brain. This type of trauma usually 
occurs when the head suddenly and violently hits an object.  Damage occurs due to 
moving back and forth in the skull as a result of acceleration or deceleration. Common 
causes of the injury are automobile accidents, violence, falls, and sports-related accidents 
[5].  About 1.5 million people in the U.S. suffer from traumatic brain injury each 
year.  About 50,000 people die from TBI each year, and 85,000 people suffer long-term 
disabilities.   In the U.S., more than 5.3 million people live with 
disabilities caused by TBI [6].  Injury to the central nervous 
system (CNS, Illustration 1-1) is particularly devastating 
because of the poor ability for neurons to regenerate their 
neurites.  This injury leads to neuronal degeneration as well as 
cell death.   
 
Animal models of injury consist of three main types: 
compression, crush, and transection injuries.  This study 
proposes to use transection or “cut or repair,” type injury. 
Transection injuries produce a Sunderland type V injury, which 
result in disruption of all the fibers.  Accordingly, recovery is 
Illustration 1-1: Schematic 




markedly worse than the lower grade injuries [7].  Hence, it will be beneficial to use 
transection as a model for a “worst case” regenerative scenario.   
Section 2: Post-Injury 
After neuronal injury, membranes reseal within 30-60 minutes [8], based on 
horseradish peroxidase uptake, after which there is a transient period of anatomical 
remodeling through local sprouting at the lesion site.  However, the severed axons 
ultimately fail to regenerate beyond the lesion site.  The distal 
ends of the severed axons form dystrophic growth cones, 
which are exposed to the damaged glial environment.  At an 
early phase of the injury, then, myelin-associated inhibitors 
restrict axon re-growth.  Next, inflammatory cells and 
reactive astrocytes lead to the formation of a glial scar.  With 
the scarring process there is release of chondrotin sulphate 
proteoglycans that further limit the regenerative process [2].  
Illustration1-2 depicts CNS injury site.   
All together, these factors are believed to prevent regeneration of the CNS.  As a 
result, identifying mechanisms that promote axonal regeneration of the damaged fibers is 
beneficial.  I hypothesize that one of the ways that might be able to promote regeneration 
is through transport of mRNAs to the distal neurites, which would then provide 
transcripts for protein synthesis, for rebuilding locally within neurites.  Some of the 
current therapies that focus on promoting regeneration are described in Section 3, and 
evidence in support of a role for local protein synthesis and mRNA transport is provided 
in Sections 4 and 5, respectively. 
Illustration 1-2: Schematic 





Section 3: Current Therapies 
Studies to promote CNS regeneration began as early as 1910’s.  The earlier 
research illustrated that CNS neurons do have regenerative capabilities when provided 
with proper environment.  More recently, several studies have been looking at different 
aspects of regeneration process.  The regeneration process of CNS requires survival, re-
growth and functional synapse formation [9]. There are many studies that focus on 
promotion of regeneration in the injured CNS.   
The many areas of regeneration studies include cellular replacement, neurotrophic 
factor delivery, axon guidance, removal of growth inhibition, manipulation of 
intracellular signaling and immune response [10].  The idea of stem cells replacing cells 
of the CNS morphologically has gained attention.  Recent studies have illustrated that 
stem cells exit in the CNS, and could be used as a source of stem cells for re-
implantation.  However, the limiting factor is to determine whether the replaced cells are 
differentiated, and functional [9,10].  Neurotrophins, a family of polypeptides, are 
believed to be responsible for keeping viability of developing neurons until the axons and 
dendrites reach appropriate target.  These neurotrophins include Nerve growth factor 
(NGF), Brain-derived neurotrophic factor (BDNF), Neurotrophin-3 (NT3), Neurotrophin-
4/5 (NT4/5), and Neurotrophin-6 (NT6).  However, an optimal way to utilize these 
factors in achieving regeneration has not yet been determined.  A few axon guidance 
molecules such as polysialic acid-containing neural adhesion molecules (NCAMs), and 
proteins such as the SLIT group are known to guide axons during development; however, 
their role post neuronal damage is not well understood [9].  The two major classes of 
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CNS regeneration inhibitors are the myelin-associated inhibitors (MAIs) and the 
chondroitin sulfate proteoglycans.  One of the MAI is Nogo-A, genetic deletion of Nogo-
A and antibodies targeting Nogo-A promotes functional recovery after spinal cord injury 
(SCI) [11,12,13,14].  Other therapies such as removal of growth factors, and 
manipulation of immune response may have potential to manipulate scar tissue that 
prevents axonal growth, and promote axonal growth by inhibiting microglial and 
macrophage activation. While these therapies largely address inhibitory factors, the 
intrinsic growth capacity of neurons is also an imperative determinant of CNS 
regeneration failure, and has been underappreciated and under-studied.  CNS neurons do 
not up regulate growth-associated genes to the same extent as do PNS neurons.  As a 
result, even in the absence of inhibitors, their ability to regenerate is limited.  Increasing 
the intrinsic growth capacity of neurons will allow modest axon regeneration within the 
CNS [11,15].  Consequently, the goal of this proposal is to provide a step forward in this 
direction by understanding intrinsic mechanisms of CNS neurons in the context of 
development and regeneration.  One such intrinsic mechanism is the ability of the cells to 
synthesize proteins locally.   
 
Section 4: Local Protein Synthesis and Regeneration 
Local protein synthesis, or synthesis away from the cell body, in neurites, is 
important for neuronal survival, development, axon guidance, synapse formation and 
refinement [16], including plasticity-linked learning and memory, and regeneration [17].  
Literature on mechanisms and regulation of local protein synthesis encompasses both the 
peripheral nervous system (PNS) and central nervous system (CNS), and within the CNS, 
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dendrites and axons.  In the PNS, evidence for local protein synthesis was presented as 
early as 1970, where ribosome-like particles were visualized by electron microscopy 
(EM) in axons [18,19].  Since then, studies have confirmed the identity of peripheral 
ribosomal domains within myelinated mammalian axons [16,20], and gene-profiling 
studies have revealed many different proteins that can be synthesized locally in axons 
[21,22].  The examination of local protein synthesis in the central nervous system 
continues to be a source of some ambiguity.  Initial studies concluded that the ribosomes 
are found in the dendrites of the hippocampal neurons, but not in the axons.  
Consequently, translational machinery and mRNAs are excluded from the axons of 
mature neurons [23,24], leading to increased attention on mRNA regulation and local 
protein synthesis in dendrites.  Developmentally, dendritic protein synthesis increases 
during synaptogenesis and decreases into adulthood [25,26].  Interestingly, the emphasis 
on dendritic protein synthesis has resulted in an underplaying of evidence supporting 
protein synthesis within CNS axons. As for the PNS and CNS neurons, axon profiling in 
the dorsal root ganglion (DRG) and hippocampus suggested that hundreds of different 
proteins can be locally synthesized [21].  Moreover, multiple components of translational 
machinery, such as signal recognition particles (SRP), ER proteins, and Golgi 
components have been observed in the axon [27]. 
The ability of neurons to re-grow in culture suggests that protein synthesis might 
be reactivated by injury.  The importance of local protein synthesis in regeneration has 
been elucidated in several studies where it was shown that axonally separated neurons 
could synthesize proteins for several hours after injury.  For instance, the study of Verma 
et al., demonstrated that axons of injured DRGs formed growth cone within 20 minutes.  
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And after 4 hours, 80% of neurons successfully regenerated a new growth cone.  They 
also illustrated impaired growth cone regenerative ability after applying protein synthesis 
inhibitors [28].  It was illustrated that the formation of growth cone requires activity of 
target of rapamycin (TOR), P38 MAPK, Caspase – 3, where TOR, and P38 MAPK 
regulate protein synthesis through translation factor activity [28,29,30].  Additionally, in 
the CNS neurons, particularly in the adult retinal ganglion cells (RGCs), deletion of 
PTEN (phosphatase and tensin homolog), a negative regulator of the mammalian target 
of rapamycin (mTOR) pathway promotes axonal regeneration after optic nerve injury.  
Specifically, PTEN deletion activates the PI3K/mTOR pathway controlling cell growth 
and size by regulating cap-dependent protein translation initiation [31].  Other 
observations illustrate protein synthesis inhibitors applied to the proximal nerve after 
axotomy can attenuate regenerative growth.  In addition, immunolocalization studies 
suggested that the ability of axonal protein synthesis correlates with their regenerative 
capacity in vivo [29,32,33].  Another piece of evidence that axonally synthesized proteins 
appear to facilitate injury responses is that injury-conditioned axons show increase in 
content of protein synthesis compared with axons from naïve neurons [28,29].  
Altogether, literature emphasize that axonal protein synthesis is important to initiate and 
maintain regeneration.  However, in order to promote axonal outgrowth and regeneration, 
it is imperative to elucidate mechanisms that are needed for local protein synthesis (LPS) 
and that require LPS.  This dissertation focuses on two processes underlying protein 
synthesis: localized mRNA transport during development, and regulation of retrograde 
injury signaling (RIS) - associated genes in the context of regeneration. 
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Section 5: mRNA Transport 
Local protein synthesis requires transport of mRNA from the cell body to 
ribosomal sites for synthesis.  Regulation of the transport of mRNA transcripts 
corresponding to proteins is also essential for local synthesis [29,34].  These regulatory 
pathways have also been studied in models of axonal injury, recovery from which 
necessitates increased local protein synthesis [35,36].  Of particular interest are the RNA 
binding proteins ZBP1, Staufen and fragile X Mental Retardation Protein (FMRP).   
The RNA binding proteins (RBPs) required to localize mRNAs are known to bind 
to 3′ untranslated regions (3′UTR) of the mRNAs.  As in the PNS, RBP have been 
implicated in coupling the transport of mRNA into dendrites with local protein synthesis 
[25].  Among these, FMRP and Cytoplasmic Polyadenylation Element Binding Protein 
CPEB bind many mRNAs important for development, including, respectively, the α-
isoform of calcium–calmodulin-dependent protein kinase II (αCAMKII), involved in 
long term potentiation, and brain derived neurotrophic factor (BDNF), responsible for 
initiating a variety of CNS signaling pathways [25,37,38].  Again, FMRP has been found 
in axons of some CNS neuronal populations [39], and the RBP zipcode binding protein-1 
(ZBP1) has been known to associate with β-actin mRNA in the chick forebrain, and 
influence its axonal transport [40,41].  In fibroblasts, localized translation of β-actin 
mRNA is needed for polarity of cell migration.  It is also evident that the localized β-
actin mRNA is translated in the axons [4,27,42,43].  In addition, ZBP1 also act as β-actin 
mRNA translation repressor since it inhibits translation of β-actin mRNA while bound.  
The β-actin mRNA translation is de-repressed by phosphorylation of ZBP1 on tyrosine 
residues by Src-family kinases, allowing dissociation of RNA-protein complex [44].  
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Another study illustrated the role of ZBP1 in regulating mRNA transport to the activated 
synapses of hippocampal neurons in response to synaptic activity [45].   Though many 
mechanisms that regulate mRNA transport have been discovered, further details need to 
be uncovered.  
Defects in several aspects of local mRNA regulation, such as those summarized 
above, have been linked to neurological disorders [25]. Furthermore, studies in the CNS 
neurons showed that localized mRNAs play a variety of functions. Most relevant to our 
work, it was illustrated that the composition of the pool of axonal mRNAs changes after 
axonal injury and during regeneration [21], and, in support of the intrinsic regenerative 
capacity of CNS neurons, mRNAs found in injured and naïve CNS axons are similar to 
those found in the PNS [46]. Detailed quantification of mRNA transport will provide a 
better understanding of mRNA trafficking in the axons, which will then allow us to 
understand the mechanisms guiding normal and altered mRNA transport, and its 
importance in neuronal regeneration.  As a result, one of the goals of our project (Chapter 
2) was to understand quantitative details of mRNA transport during hippocampal neuron 
development. 
Section 6: Retrograde Injury Signaling (RIS) Mechanisms 
Retrograde injury signaling (RIS) may be defined as the transport of injury signals 
from the site of injury to the nucleus in the cell body. This mechanism appears to play a 
major role in the regenerative process in the PNS [36,47].  
Upon injury, the rapid ion influx at the injury site generates an 
electrophysiological response that propagates retrogradely to provide the first indication 
of lesion events [47,48,49].  Slower components of the RIS result in decreased trafficking 
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of trophic factors to the soma, and increased transport of new-injury induces signals from 
the site of injury to the nucleus [47,50,51].  RIS complexes require importin α, importin 
β1 (also known as Karyopherin beta 1), RanBP1, and signaling cargoes in association 
with dynein motors [47,51,52,53]. The importin β1 mediated RIS mechanism is very 
important for axonal regeneration, as the axonal knockout of importin β1 attenuates cell 
body transcriptional responses to nerve injury and delays functional recovery in vivo 
(Illustration 1-3) [54].  In particular, injury induces local translation of importin β1 and 
Ran-binding protein (RanBP1) in the axons [36], which reverses the prevention of 
importin-associated cargo complex imposed by RanGTP. Several signaling cargoes and 
associated signaling molecules have been identified in the RIS complex. Among the 
cargoes is the type III intermediate filament, vimentin, which links activated Erks to 
importin-mediated retrograde transport and protects ErK from desphosphorylation [55].   
Retrograde signaling has been extensively studied in the PNS, towards new 
approaches to enhance regeneration. In the CNS, importin β1 is shown to transport the 
transcriptional regulator STAT after injury, indicating its role in injury-induced 
axonogenesis of hippocampal neurons [56,57]. 
 
Illustration 1-3: Schematic of Retrograde injury signaling pathway.  
Injury triggers translation of several proteins.  Upon local synthesis, these proteins form into a 
complex. The trimeric complex then binds to specific cargo. The cargo is transported back to the 




 However, major knowledge gaps exist both in the PNS and CNS, including an unclear 
understanding of mechanisms underlying the regulation of local transcriptional levels of 
RIS associated genes, which encode RIS-associated proteins activated in response to 
injury.  Additionally, injury induced local translation of importin β1, and associated 
proteins RanBP1, and vimentin have not been elucidated in the CNS.  In Chapters 3 and 
4, I detail the mechanisms underlying the regulation of axonal levels of RIS associated 
genes in response to injury utilizing whole hippocampal explant culture system.  
Section 7: Summary 
As described above, CNS neurons' ability to regenerate is less efficient than PNS 
neurons.  In addition, more research has been performed on PNS neurons compared to 
those in the CNS, due to easily accessible and long peripheral axons, both in vitro and in 
vivo.  Our goal was to elucidate specific intrinsic mechanisms: mRNA Transport and RIS 
process in the central nervous system.  Unveiling these specific neuronal intrinsic 
mechanisms will be beneficial in promoting axonal regeneration.  First, I have provided 
the first rigorous quantitative assessment of axonal and dendritic mRNA transport during 
central neuronal development. Significant differences in the transport parameters for 
individual and pooled particles at different stages of neuronal maturity emphasize the 
dynamic nature of transport at multiple levels.  As a matter of fact, using our mRNA 
transport results, average net velocity of .002 µM/sec and maximum velocity of .03 
µM/sec suggests that within 1 hour and 24 hours, mRNA can be transported to the 
distance of 7.2 µM-108 µM within 1 hour, and to the distance of 173µM - 2592 µM 
within 24 hours.  Second, I have unfolded details of the RIS associated mRNAs 
mechanisms utilizing a novel hippocampal explant culture system. Particularly, our 
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results suggest a biphasic axonal response, in which levels of several axonal transcripts, 
including those associated with RIS, increase rapidly in axons after injury, contributing to 
early synthesis of corresponding proteins. Importin β1-dependent activity at the nucleus 
then appears to modulate a second wave of RIS-associated transcripts, which are likely to 
further support axonal outgrowth. These studies provide insight into a powerful set of 





Chapter 2: A comparative quantitative assessment of axonal and 
dendritic mRNA transport in maturing hippocampal neurons 
 
Section 1: Abstract 
 
Translation of mRNA in axons and dendrites enables a rapid supply of proteins to 
specific sites of localization within the neuron. Distinct mRNA-containing cargoes, 
including granules and mitochondrial mRNA, are transported within neuronal 
projections. The distributions of these cargoes appear to change during neuronal 
development, but details on the dynamics of mRNA transport during these transitions 
remain to be elucidated.  For this study, we have developed imaging and image 
processing methods to quantify several transport parameters that can define the dynamics 
of RNA transport and localization. Using these methods, we characterized the transport 
of mitochondrial and non-mitochondrial mRNA in differentiated axons and dendrites of 
cultured hippocampal neurons varying in developmental maturity. Our results suggest 
differences in the transport profiles of mitochondrial and non-mitochondrial mRNA, and 
differences in transport parameters at different time points, and between axons and 
dendrites. Furthermore, within the non-mitochondrial mRNA pool, we observed two 
distinct populations that differed in their fluorescence intensity and velocity. The net 
axonal velocity of the brighter pool was highest at day 7 (0.002 ± 0.001 µm/s, mean ± 
SEM), raising the possibility of a presynaptic requirement for mRNA during early stages 
of synapse formation. In contrast, the net dendritic velocity of the brighter pool increased 
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steadily as neurons matured, with a significant difference between day 12 (0.0013 ± 
0.0006 µm/s) and day 4 (-0.003 ± 0.001 µm/s) suggesting a postsynaptic role for mRNAs 
in more mature neurons.  The dim population showed similar trends, though velocities 
were two orders of magnitude higher than of the bright particles. This study provides a 
baseline for further studies on mRNA transport, and has important implications for the 
regulation of neuronal plasticity during neuronal development and in response to 
neuronal injury. 
 
Section 2: Introduction 
 
The geometry and unusual polarity of neurons imposes a tremendous challenge on 
biological communication between the cell body and neuronal projections such as axons 
and dendrites. One such challenge is the appropriate localization of translated proteins, 
which can vary depending on intracellular and extracellular cues [42].  A large fraction of 
protein deployment within neuronal projections occurs through the active or passive 
transport of proteins synthesized in the cell body [58]. Alternately, increasing evidence 
suggests that proteins may be translated locally, along an axon or dendrite or at their 
termini [18,19,21,29,59,60]. Though synthesis may occur within neurites, mRNA must 
still be transported, often as part of a granular complex containing additional translational 
and regulatory machinery, from the cell body to sites of local translation. Local synthesis 
has been linked to neuronal development, survival, and learning and memory [17]. 
Specific activities playing a role in these processes include axon guidance, synapse 
formation and synaptic refinement [16]. Clinically, defects in local mRNA regulation 
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have been linked to several neurological disorders, including fragile X syndrome and 
spinal muscular atrophy [25].  
Previous work on mechanisms and regulation of local protein synthesis has been 
performed in both the peripheral nervous system (PNS) and central nervous system 
(CNS). In the PNS, evidence for local protein synthesis was presented as early as 1970, 
when ribosome-like particles were visualized in axons by electron microscopy (EM) 
[18,19,60].  Since then, studies have confirmed the identity of peripheral ribosomal 
domains within myelinated mammalian axons [16,20], and gene-profiling studies have 
revealed many different proteins that can be synthesized locally in axons [21,29,59].  
Regulation of the transport of mRNA transcripts corresponding to these proteins is also 
essential for local synthesis. Recent work suggests that mRNA transport is tightly 
coupled to the activation of local protein synthetic pathways, possibly through signaling 
pathways initiated by growth factors [34,59]. These regulatory pathways have also been 
studied in models of axonal injury, recovery from which necessitates increased local 
protein synthesis [4,36,59].  Of particular interest are RNA binding proteins (RBP) such 
as Staufen and fragile X mental retardation protein (FMRP), which regulate the 
distribution of mRNA. 
In the CNS, compelling functional roles for local protein synthesis have been 
identified in development as well as the regulation of synaptic stabilization, long-term 
potentiation or depression (LTP or LTD), and the consolidation of memory. Translational 
profiling and localization studies suggest that hundreds of different proteins can be 
locally synthesized in the axons [21] and dendrites [61]. In addition, multiple components 
of translational machinery, such as mRNA, signal recognition particles (SRP), ER 
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proteins, and Golgi components have also been observed in the axons [27] and in 
dendrites [5, 6]. Developmentally, dendritic protein synthesis increases during 
synaptogenesis and decreases into adulthood [24,25]. As in the PNS, several RBP have 
been implicated in coupling the transport of mRNA into axons and dendrites with local 
protein synthesis [25,37].  
Collectively, studies in both the PNS and CNS reveal multiple conceptual 
similarities in hypothesized mechanisms guiding the coupling of mRNA transport and 
translation. However, a significant gap in our understanding of this coupling persists, in 
part due to a lack of rigorous criteria by which transport may be assessed and compared. 
As a first step towards filling this gap, we have developed methods to quantify several 
parameters that describe the dynamics of mRNA transport and localization. Using these 
methods, we compared mRNA transport in the axons and dendrites of cultured 
hippocampal neurons at various stages of neurite outgrowth and developmental maturity. 
We have validated these methods by comparing mRNA transport to that of mitochondria, 
a well-characterized transport cargo. Our results provide a baseline for future studies on 
mRNA transport, and raise interesting hypotheses regarding the plasticity of transport 
during hippocampal development. 
 
Section 3: Results 
Subsection 1: Localization of RNA granules in maturing hippocampal neurites 
Immunofluorescence and DIC imaging were performed to examine mRNA 
localization at different phases of developmental maturity and within hippocampal 
neurites of different polarity. At days 4, 7, and 12, several criteria were used to determine 
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the developmental phase of the neurons and to assess polarity. First, we tested whether a 
neurite contacted another cell. At day 4, the majority of neurites displayed a free growth 
cone, while at days 7 and 12, the termini of most neurites intersected with other cells. At 
day 12, there was also significantly more axonal branching per neuron compared to day 7 
(9.0 ± 1.3 vs. 2.5 ± 1.08; Mean ± SEM; t-test p<0.04), though the total number of 
projections and dendritic branching per neuron was unchanged. Second, the synaptic 
vesicle protein synapsin I was labeled to determine synaptic maturity [62,63]. At day 4, 
as expected based on previous work [23], synapsin localized primarily as small puncta 
along neurites and as larger densities at terminal growth cones (Fig 1a). By day 7, larger 
densities of synapsin I were observed, with accumulations of vesicles at sites of neurite 




Figure 2-1: Maturity of hippocampal neurons at different days in culture.  
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The synaptic vesicle protein Synapsin I is a marker for the maturity of the hippocampal neurons 
[62]. Immunolabeling with Synapsin I at day 4 (A) shows granular proteins concentrated in the distal 
axon and growth cone, as there is no cell-cell contact (arrow – protein in distal axon, circle- protein 
in growth cone), while there is a considerable increase in fluorescence intensity at day 7 (B). There is 
formation of large cluster of vesicles at sites of synaptic contact at day 7 (Circles-shows cell 
connection). The images illustrated here have been converted to grayscale and contrast enhanced, to 
emphasize neurites. Bar is 50µm.  
 
To differentiate between dendrites and axons, we examined the geometry of 
neurites under DIC and fluorescence imaging. As previously described [64,65,66], axons 
exhibited a long, narrow process that emerged from the cell body with minimal tapering 
and dendrites displayed a shorter process that tapered more gradually as it emerged from 
the cell body (Fig 2). We confirmed morphological assessments with 
immunofluorescence; axons were identified through the labeling of phosphorylated 
neurofilaments (SMI-31) and dendrites by MAP2 (Fig 2). Spatially distinct SMI-31 and 
MAP2 labeling was apparent as early as day 3 (data not shown). However, the 
fluorescence pattern was more continuous within each neurite at days 4, 7, and 12 (Fig 
2a-c), confirming that neurons had fully differentiated at our earliest time point. Based on 
these criteria, then, neurons at day 4 with a free terminal were designated as immature 
(growing), differentiated neurons. Neurons at days 7 and 12 were both designated as 





Figure 2-2: Hippocampal neurons are differentiated and present distinct morphology for both the 
axon and dendrites.  
Dendrites have shorter process and taper more gradually (arrows), while axons display a long, 
narrow process with minimal tapering (arrows in all figures). (A-C) Expression of phosphorylated 
neurofilaments SMI-31 (red) and microtubule-associated protein MAP2 (green) (A) Double-label 
immunofluorescence of SMI-31 (red) and MAP2 (green) at 4 DIV (days in vitro).  Dendrites (MAP2) 
are shorter with gradual tapering projections whereas axon (SMI-31) stain display long narrow 
processes. (B) Double-label immunofluorescence of SMI-31 (red) and MAP2 (green) at 7 DIV. (C) 
Double-label immunofluorescence of SMI-31 (red) and MAP2 (green) at 12 DIV. Bar is 50µm.  
 
To ascertain the localization of axonal and dendritic mRNA particles at each stage 
of development, cells were labeled with Syto, a nucleic acid stain that labels RNA in both 
intra- and extra-nuclear compartments of the cell [67,68]. Syto co-localized with nuclei 
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labeled with Hoechst dye and also localized to neurites (Fig 3). 
 
Figure 2-3:Hippocampal neurons were co-labeled with Syto nucleic acid stain and Hoechst nuclear 
stain.  
Syto and Hoechst co-localize within the cell body (arrows), but there is no Hoechst labeling in 
neurites, which display Syto fluorescence. (A) Neurons stained with Syto nucleic acid stain (green). 
(B) Neurons stained with Hoechst nuclear stain (blue). (C) Double-label of Syto (green) and Hoechst 
(blue). Bar is 20µm.  
 
Morphological assessment under DIC imaging conditions and counterstaining with SMI-
31 and MAP2 antibodies revealed that RNA localized to both axons and dendrites (Fig 
4,5). To differentiate non-mitochondrial RNA from mitochondrial mRNA in these 
processes, neurons were co-labeled with Syto and MitoTracker. RNA puncta that did not 
co-localize with MitoTracker within a neurite were designated as non-mitochondrial 
particles of mRNA (Fig 6b-d). The likelihood of a particle being mistakenly labeled as 
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non-mitochondrial (i.e., a false positive) was low, given the high affinity and 
fluorescence intensity of MitoTracker. Subsequent kymograph analysis was performed on 
labeled non-mitochondrial mRNA (referred to from now as mRNA) and mitochondria to 
distinguish between the movements of these two spatially and functionally distinct 




Figure 2-4:Confocal microscopy of mRNA localization in axons.  
(A,D) Double-label immunofluorescence shows Syto labeling in cell bodies (nuclear) and co-
localization of mRNA (Syto, green) with an axonal marker (SMI-31, red). Green puncta (Syto) that 
are not co-labeled correspond to localization within dendrites. (Inset – expanded for more clear 
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visualization).  (B, E) Immunofluorescence of mRNA (Syto, green).  (C,F) Immunofluorescence of 




Figure 2-5:Confocal microscopy of mRNA localization in dendrites. 
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(A) Double-label immunofluorescence shows Syto labeling in cell bodies (nuclear) and co-localization 
of mRNA (Syto, green) with a dendritic marker (MAP2, red). Green puncta (Syto) that are not co-
labeled correspond to localization within axons. (B) Immunofluorescence of mRNA (Syto, green). (C) 
Immunofluorescence of dendritic marker (MAP2, red). Bar is 50µm.  To differentiate non-
mitochondrial RNA from mitochondrial mRNA in these processes, neurons were co-labeled with 
Syto and MitoTracker. RNA puncta that did not co-localize with MitoTracker within a neurite were 
designated as non-mitochondrial particles of mRNA (Fig 6b-d). The likelihood of a particle being 
mistakenly labeled as non-mitochondrial (i.e., a false positive) was low, given the high affinity and 
fluorescence intensity of MitoTracker. Subsequent kymograph analysis was performed on labeled 
non-mitochondrial mRNA (referred to from now as mRNA) and mitochondria to distinguish 




Figure 2-6: Methods of image analysis. 
Time-lapse images of neurites were taken under DIC and fluorescence conditions. After classifying 
the neurite as an axon or dendrite using the DIC image, RNA particles (Syto, green) and 
mitochondrial particles (Mitotracker, red) were fluorescently labeled. (A) DIC image of a neurite (B) 
Both mitochondrial (B) and non-mitochondrial RNA and (C) non-mitochondrial kymographs were 
generated along the length of the neurite visible in the imaging field.  Particles that were present in 
both of the kymographs were concluded to be mitochondrial mRNA whereas particles that were only 
present in the non-mitochondrial RNA kymograph were considered mRNA particles (arrows).  (D) 
Overlay of mRNA kymograph (green) and mitochondrial kymograph (red). (E) mRNA kymograph 
without contrast enhancement. (F) Kymograph from (E) following iterative overlay of 50% 
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transparent image to visualize dim moving particles. (G) Kymograph from (E) following contrast 
enhancement to visualize dim mRNA moving particles. Additional details on enhancement of dim 
particles are shown in Figure S1. Bar is 20µm. 
  
RNase treatment was performed to test whether “dim” particles labeled with Syto 
were mRNAs (Fig 7).  Bright and dim mRNA particles were observed in kymographs of 
Syto, captured for only 5 minutes to minimize bleaching artifacts. Ribonuclease A 
treatment resulted in complete deletion of Syto signal in the neurites, and a strong 
suppression of signal in the cell body. Post-RNase, no puncta along the axon were as 
intense as the dimmest visible particle pre-RNase, suggesting that Syto indeed labeled 




Figure 2-7: RNase A treatment was done to ascertain that dim particles are in fact mRNA particles.  
(A) Kymographs of mRNA particles pre-RNase treatment. (B) Neurons stained with Syto nucleic 
acid stain (green). (C) Neurons stained with Syto nucleic acid stain frame #3 (green). (D) Neurons 
stained with Syto nucleic acid stain frame #11 (green).  The arrows indicate corresponding “dim” 
particle as it moves over five minutes. The bright particle indicated with down arrow had an average 
intensity of 9.26 arbitrary units, and dim particle indicted with up arrow had an average intensity of 
0.98 arbitrary units. Values account for background subtraction. (E) Corresponding neuron after 
RNase treatment showing no Syto signaling in the neurites. Puncta indicated by arrows pre-RNase 
had intensities indistinguishable from background levels. All images are shown contrast enhanced, 
confirming full suppression of neurite fluorescence. (F) Cropped kymograph enlarged, from (A). (G) 
Corresponding region from (B) enlarged, including dim particle. Bar is 20µm. 
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Subsection 2: mRNA transport in dendrites and axons 
Initial inspection of kymographs indicated 20-30 total fluorescent particles in each 
axon, with about half associated with mitochondria and half unassociated. Qualitatively, 
these particles appeared to move bidirectionally over short distances at slow rates. Closer 
inspection after the contrast enhancement of kymographs revealed another population of 
particles with very low fluorescence (Fig 6e-g). These particles were difficult to find in 
individual frames of time-lapse movies as well as non-enhanced kymographs; therefore, 
we applied a sequence of image processing algorithms to enhance their contrast and 
confirm their presence (Fig 6e-g, Fig 8 and 9). These particles appeared more mobile than 
their bright counterparts, and did not co-localize with mitochondria. Given the possibility 
that these visually distinct pools of mRNA, designated as “bright” and “dim,” could have 
different functional roles, we analyzed their transport profiles separately rather than 




Figure 2-8: Methods of image analysis. Time-lapse images of neurites were taken under DIC and 
fluorescence conditions.  
After classifying the neurite as an axon or dendrite using the DIC image, RNA particles (Syto, green) 
and mitochondrial particles (Mitotracker, red) were fluorescently labeled to identify respective 
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particles. Contrast enhancement and several controls were performed to confirm dim particles. (A) 
Non-mitochondrial mRNA kymograph without contrast enhancement. (B) ) Kymograph from (A) 
following iterative overlay of 50% transparent image to visualize dim moving particles (C) 
Kymograph from (B) inverted using ImageJ to visualize dim particles (arrow). (D) Kymograph from 
(B). (E) Kymograph from (D) following contrast enhancement in ImageJ to visualize dim particles 
(arrow). (F) Kymograph from (D) inverted and contrast enhanced (arrow). (G) Kymograph from 
(B).  Local contrast enhancement improved dim particle visualization. (H) Selection of background 
region with no apparent particles (yellow lines) for contrast enhancement.  (I) Kymograph from (H) 
following local contrast enhancement does not indicate a particle trajectory in selected region (oval), 
confirming validity of contrast enhancement. (J) Kymograph from (B).  (K) Selection of region of 
interest (ROI-yellow lines) for local contrast enhancement to visualize dim particles. (L) Kymograph 
from (K) following local contrast enhancement to visualize dim particles (arrow).  
 
Figure 2-9: Time-lapse images of neurites were taken under DIC and fluorescence conditions. 
 After classifying the neurite as an axon or dendrite using the DIC image, RNA particles (Syto, green) 
and mitochondrial particles (Mitotracker, red) were fluorescently labeled to identify respective 
particles. (A) Whole kymograph following iterative overlay of 50% transparent image to visualize 
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dim moving particles (arrows). (B) Kymograph from (A) cropped upper region to visualize dim 
particles (arrows).  (C) Kymograph from (B) inverted to visualize dim particles (arrows). (D) 
Kymograph from (A) after cropping lower region to visualize dim particles (arrows).  (E) 
Kymograph from (C) inverted to visualize dim particles (arrows). Bar is 20µm. 
 
A detailed assessment of transport involved the extraction of several parameters, 
which are summarized in Table 1.  The comparison of pooled particles of a particular 
identity (directionality and net velocity) is presented in Fig 10 and Fig 11. These 
parameters are attained from comprehensive raw data that describe the movement of 
individual particles (particle velocity and duration). For convenience, Tables 2 and 3 
summarize results for all parameters and may serve as a useful roadmap through the 
extensive datasets. Raw data and their statistical comparisons are also presented as 
figures and supplementary tables (Fig 12-14, Table S1-S4). 
Table 2-1: Summary of measured parameters used to describe transport profiles for individual 




The maximum velocity achieved during the 
lifetime of a particle in each direction 
Average 
Velocity 
The average velocity during the lifetime of a 
particle in each direction 
Duration The amount of time spent by a particle moving in 
each direction during its lifetime 
Directionality The net direction that a given particle moves over 
its lifetime within a neurite 
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Figure 2-10: Net directionality of particle movement over its lifetime.  
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mRNA and mitochondrial particles were categorized as either moving or stationary.  They were 
considered moving if their average velocity in either direction was greater than 0.001 µm/sec 
(0.1mm/day).  Particles that did not meet this criterion were designated stationary.  (A) percent of 
bright mRNA particles in axons in each state for days 4, 7, and 12. (B) Percentage of bright mRNA 
particles in dendrites in each state for days 4, 7, and 12.  There are significantly more moving 
particles in anterograde direction at day 12 compared to day 4 p <0.02 (ANOVA:Tukey). In contrast, 
there are significantly more stationary particles at Day 7 compared to Day 12 p<0.05 
(ANOVA:Tukey). (C) Percentage of dim mRNA particles in axons in each state for days 4, 7, and 12. 
(D) Percentage of dim mRNA particles in dendrites in each state for days 4, 7, and 12.  
 
Figure 2-11: Average net velocity of individual dim and bright mRNAs particles in axons and 
dendrites.  
(A) Average of net bright mRNA velocity moving through axons. (B) Average of net bright mRNA 
velocity moving through dendrites.  The net velocity is higher at day 12 compared to day 4 p< 0.05 
(ANOVA:Tukey).  (C) Average of net dim mRNA velocity moving through axons. (D) Average of net 





















velocities for various classes of labeled cargoes. Dash indicates no significant difference for a given 











Cargo Population Analysis Net Velocity 
mRNA in Dendrites (Dim) - day 4 vs. ↑day 12 
mRNA in Axons (Bright) - - 
mRNA in Dendrites 
(Bright) 
↑day 7 vs. day 12 (stat) 
day 4 vs. ↑day 12 (Ante) - 
Mitochondria in Axons day 4 vs. ↑day 7 (Ante) - 
Mitochondria in Dendrites - 
day 4 vs. ↑day 7 















Table 2-3: Summary of statistically significant differences in maximum velocities and track durations 





difference for a 
given parameter. 


















Track Velocity Track Duration 
mRNA Axon 
anterograde (Dim) - - 
mRNA Axon 
retrograde (Dim) - 
day 4 vs. ↑day 12 
↑day 7 vs. day 12 
mRNA Dendrite 
anterograde (Dim) day 7 vs. ↑day 12 - 
mRNA Dendrite 
retrograde (Dim) - - 
mRNA Axon 
anterograde (Bright) ↑day 7 vs. day 12 - 
mRNA Axon 
retrograde (Bright) day 4 vs. ↑day 7 - 
mRNA Dendrite 
anterograde (Bright) 
day 4 vs. ↑day 7 
day 4 vs. ↑day 12 
↑day 7 vs. day 12 - 
mRNA Dendrite 
retrograde (Bright) - - 
mRNA Dendrite 
retrograde (Bright) - - 
Mitochondria Axon 
anterograde 
day 4 vs. ↑day 12 
↑day 7 vs. day 12 
day 4 vs. ↑day 12 
day 7 vs. ↑day 12 
Mitochondria Axon 
retrograde 
↑day 4 vs. day 12 
↑day 7 vs. day 12 
↑day 4 vs. day 12 
↑day 7 vs. day 12 
Mitochondria Axon 
anterograde N/A N/A 
Mitochondria 
Dendrite anterograde 
day 4 vs. ↑day 7 
day 4 vs. ↑day 12 
↑day 7 vs. day 12 - 
Mitochondria 



















Figure 2-12: Maximum track velocity of mRNA in axons and dendrites. Particles were considered 
moving if their average velocity in either direction was greater than 0.001 µm/sec (0.1mm/day).  
(A) Maximum track velocity of bright and dim mRNAs moving through axons in the 
anterograde direction.  Within the bright mRNA population, particles moved more slowly at day 12 
compared with day 7 (p< 0.002, K-S test). (B) Maximum track velocity of bright and dim mRNA 
particles moving through axons in the retrograde direction.  Within the bright mRNA population, 
there is a rightward shift. Overall, more particles moved faster at day 7 compared to day 4 (p< 0.03, 
K-S test). (C) Maximum track velocity of bright and dim mRNA particles moving along dendrites in 
the anterograde direction.  Within the bright mRNA population, there was a leftward shift. 
Significantly different velocities were observed for all days; however, at day 12 there were more 
particles that moved slowly (p< 0.05, K-S test).  Within the dim population, there were significantly 
more particles that moved faster at day 12 compared to day 7 (p< 0.01, K-S test). (D) Maximum 




Figure 2-13: Distributions of track movement durations of mRNA in axons and dendrites were 
calculated from kymographs for days 4, 7, and 12.  Only particles classified as moving were analyzed.  
Individual particle durations are presented as cumulative histograms.  (A) Track durations of bright 
mRNA particles moving through axons in the anterograde direction. (B) Track durations of bright 
mRNA particles moving through axons in the retrograde direction. (C) Track durations of bright 
mRNA particles moving through dendrites in the anterograde direction. (D) Track durations of 
bright mRNA particles moving through dendrites in the retrograde direction. (E) Track durations of 
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dim mRNA particles moving through axons in the anterograde direction. (F) Track durations of dim 
mRNA particles moving through axons in the retrograde direction. Distributions were significantly 
different for days 4 vs. day 12 (p < 0.03, K-S test) and at day 7 vs. day 12 (p < 0.04, K-S test). (G) 
Track durations of dim mRNA particles moving along dendrites in the anterograde direction. (H) 




Figure 2-14: Maximum track velocities and movement durations of mitochondria in axons and 




(A) Maximum track velocity of mitochondria moving through axons in the anterograde direction. 
Distributions of maximum mitochondrial velocities were significantly different at day 4 compared to 
day 12 (p < 0.005, K-S test), and at day 7 compared to day 12 (p < 0.001, K-S test). (B) Maximum 
track velocities of mitochondria moving through axons in the retrograde direction. Distributions of 
maximum mitochondrial velocities were significantly different at day 4 compared to day 7 (p <0.03, 
K-S test), and at day 7 compared to day 12 (p < 0.03, K-S test). (C) Maximum track velocities of 
mitochondria moving through dendrites in the anterograde direction. Distributions of maximum 
mitochondrial velocities were significantly different at day 4 compared to day7 (p< 0.02, K-S test) at 
day 4 compared to  day 12 (p <0.001, K-S test) and  at day 7 compared to day 12 (p < 0.008, K-S test).  
(D) Maximum track velocity of mitochondria moving through axons in the retrograde direction. 
Distributions of maximum mitochondrial velocities were significantly different at day 4 compared 
day 12 (p <0.02, K-S test). (E) Track durations of mitochondria moving through axons in the 
anterograde direction. Distributions of durations were significantly different at day 4 compared to 
day 12 (p <0.0007, K-S test), and at day 7 compared to day 12 (p < 0.0001, K-S test). (F) Track 
durations of mitochondria moving through axons in the retrograde direction. Distributions of 
durations were significantly different at day 4 compared to day 12 (p < 0.0001, K-S test) and at day 7 
compared to day 12 (p < 0.001, K-S test). (G) Track durations of mitochondria moving through 
dendrites in the anterograde direction. (H) Track durations of mitochondria moving through 
dendrites in the retrograde direction. Distributions of durations were significantly different at day 4 
compared to day 12 (p <0.02, K-S test).  
 
Maximum and average velocity: Maximum and average directional velocities of 
mRNA particles in axons and dendrites were measured at different stages of neuronal 
maturity. For bright mRNA particles, two-way ANOVA indicated no effect of the type of 
neurite, no effect of stage of maturity and no interaction effect on maximum or average 
anterograde velocity; however, significant effects of the type of neurite (p< 0.005), stage 
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of maturity (p < 0.01), and their interaction (p < 0.0001) were observed on maximum and 
average retrograde velocities (Table S1).  
Several interesting features emerged when distributions of velocities were 
compared. (Similar conclusions were obtained for both maximum and average velocities; 
for clarity, we have only shown figures for distributions of maximum velocities). In 
axons, bright mRNA particles showed significant differences in the distribution of 
maximum velocities in the anterograde direction between days 7 and 12 (p < 0.002) and 
in the retrograde direction between days 4 and 7 (p < 0.03; Fig 12a-b). Anterograde 
particles in dendrites also showed a significant difference in the maximum velocity 
distributions at day 12 compared to day 4 (Fig 12c-d), associated with a leftward shift of 
the distribution (decreased velocities). As suggested by the strong rightward shift in their 
velocity distribution, dim particles were faster than bright particles (p < 0.0001, Fig 12a-
d). Two-way ANOVA revealed a significant effect of the type of neurite (p < 0.0013), 
and stage of maturity (p < 0.03), but no interaction effect on dim anterograde mRNA 
velocity. There was no significant effect of type of neurite, stage of maturity, or their 
interaction on dim retrograde mRNA velocity. Comparisons of distributions of velocities 
also revealed no significant differences. 
Directionality analysis: To generate additional perspective on the overall 
movement patterns of individual mRNA particles, they were classified into anterogradely 
moving, retrogradely moving, bidirectionally moving, or stationary populations. Within 
axons, most bright mRNA particles were mobile (at least 75% at all days). Concurrent 
with a decrease in the proportion of stationary particles, the proportion of directionally 
moving particles (either anterograde or retrograde) significantly increased between day 4 
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and day 7 (~35% vs. ~70%) before decreasing again to an intermediate value at day 12 
(~50%). Though movement reflected an anterograde bias at all three days (Fig 6a), there 
were no significant differences in anterograde or retrograde populations across days. This 
general trend was mirrored in the dim pool of particles as well (Fig 10c). In this case, 
increases in the anterograde population between days 4 and 7 were balanced by a 
corresponding decrease in the retrograde pool.  
In dendrites, most bright particles were also classified as mobile, with all particles 
moving by day 12 (Fig 10b). This correlated with significant differences in stationary 
mRNA particles detected between days 7 and 12. Significant differences in directionality 
were also observed with increasing dendritic maturity. The proportion of particles 
moving anterogradely increased steadily with time, with nonsignificant differences being 
detected between days 4 and 7 (Fig 10b; 0% and 25%, respectively) and significant 
differences being detected between days 4 day 12 (57%). In contrast, the proportion of 
particles moving retrogradely decreased steadily over time, though no significant 
differences were detected between any days. The anterograde bias was more pronounced 
in the dim pool of mRNA particles (Fig 10d), with ~70% of the particles moving 
anterogradely at days 4 and 7, and ~85% moving anterogradely at day 12. 
 
Duration of directional movements: We also calculated the percentage of time 
that mRNA and mitochondria spent moving in each direction within axons and dendrites 
at each time point. Two-way ANOVA of dim mRNA particles detected effects of the 
type of neurite (p < 0.009), but no effect of maturity or interaction on anterograde and 
retrograde durations. For bright mRNA particles, analysis of distributions indicated a 
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trend towards longer durations in both anterograde and retrograde directions at later days 
in both axons and dendrites, though there were no significant differences in the 
distributions of the durations in either direction (Fig 12a-d). In contrast, dim particles did 
not show any trends towards increased duration at later days in axons or dendrites. In 
fact, anterograde durations in dendrites were actually slower at days 7 and 12 compared 
to day 4, with significant differences between day 4 and 7 (p < 0.03), and day 7 and 12 (p 
< 0.04) in the retrograde direction.  
 
Net velocity: In order to extrapolate transport characteristics of individual mRNA 
particles to bulk transport at different stages of axonal and dendritic development, we 
estimated net velocities for specific classes of particles at a given stage of maturity. Net 
velocity calculations combined the individual characteristics of each particle into an 
aggregate measure of directional transport. Several interesting trends were observed. The 
net velocity of bright mRNA within axons was highest at day 7, at early stages of synapse 
maturity, but decreased sharply at day 12 (Fig 11a). In contrast, net velocity for bright 
particles moving within dendrites continued to increase through day 12, with significant 
difference between day 4 and day 12 (p < 0.05, Fig 11b). Net velocity attributed to dim 
mRNA particles revealed similar trends in axons; however, the velocities were two orders 
of magnitude higher (Fig 11c). In dendrites, net velocity was always positive, and 
experienced a slight decline at day 7 before rebounding at day 12 (Fig 11d). 
 
To investigate the relative contributions of individual parameters to net velocity, 
and thus perhaps glean some insight into regulatory mechanisms, we performed multiple 
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linear regression analysis, with net velocity as the dependent variable and velocity and 
duration as independent variables. As reflected by their higher beta weights, velocities 
were for each group predominantly, though not exclusively, the dominant independent 
variable (Table 4). However, r2 values were surprisingly low, given that the independent 
variables reflected parameters used to calculate net velocity (Table 4). This perhaps 
implies the importance of relative proportions of directionally moving particles, which 
could not be captured in regression analysis. 
Table 2-4:Results comparing beta coefficients. Bold indicates dominant variable 
Experiment Variable Coefficient R-squared variable coeff 
Mitochondria  Axon Velocity 0.18 0.04 duration -0.047 
Mitochondria Dendrites  Velocity 0.43 0.15 duration 0.15 
mRNA Axon Bright  Velocity 0.75 0.58 duration -0.02 
mRNA Axon Dim  Velocity 0.52 0.21 duration 0.18 
mRNA Dendrites Bright  Velocity -0.34 0.11 duration -0.001 
mRNA Dendrites Dim Velocity 0.54 0.22 duration 0.15 
 
Subsection 3: Mitochondrial transport in dendrites and axons 
 
Maximum and average velocity: For mitochondria, there was an effect of the type 
of neurite (p < 0.02), but no effects of the stage of maturity or interaction effect on 
maximum anterograde velocities. There were also no effects of the type of neurites, stage 
of maturity, or their interaction on velocities in the retrograde direction.  When 
distributions were compared, in axons, mitochondria revealed significant differences in 
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their maximum velocity between days 4 and 12, and days 7 and 12 in both anterograde 
and retrograde directions (Fig 14a-b). In dendrites, mitochondria also showed significant 
differences in the maximum anterograde velocity among all three days. However, in the 
retrograde direction, significant differences were only found between days 4 and 12 (Fig 
14c-d). Though significant, differences in the distributions in both axons and dendrites 
appear subtle visually, and likely reflect differences in the percentage of mitochondria 
moving at the slowest velocities (left-most bin). 
Directionality analysis: Mitochondria displayed a different movement profile than 
mRNA. In general, mitochondria were less mobile in axons, though there were more 
moving particles at day 7 (76%) compared to days 4 and 12 (63% and 55%, respectively). 
Of the unidirectionally moving particles, there were more retrograde particles than 
anterograde particles at days 4 and 7. Significant differences within a particular 
population were only found between days 4 and 7; more particles moved anterogradely at 
day 7 compared to day 4 (p< 0.05), concurrent with a reduction in “wiggling” 




Figure 2-15: Net directionality of mitochondria particle movement over its lifetime. 
Particles were considered moving if their average velocity in either direction was greater than 0.001 
µm/sec (0.1mm/day).  Particles that did not meet this criterion were designated stationary. (A) 
Percent of mitochondria in axons in each state for days 4, 7, and 12.  There are significantly more 
particles moving in anterograde direction at day 7 compared to day 4 *p<0.05 (ANOVA: Tukey).  (B) 
Percent of mitochondria in dendrites in each state for days 4, 7, and 12. Average net velocity of 
individual mitochondria particles in axons and dendrites. (C) Average of net mitochondrial velocity 
moving through axons (D) Average of net mitochondrial velocity moving through dendrites.  The net 
velocity is higher at day 7 compared to day 4 (p< 0.05) and at day 12 vs. day 4 (p<0.05; 
ANOVA:Tukey). Plotted values indicate mean ±  SEM. 
 
In dendrites, there were no significant differences found.  However, as was the 
case for mRNA, there was a strong trend towards increased anterograde mitochondrial 
transport over time. Between days 4 and 7, this increase occurred concurrently with a 
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decrease in retrograde particles. Between days 7 and 12, both anterograde and retrograde 
populations increased as stationary populations decreased. 
Duration of directional movements: Mitochondria, like bright mRNA, increased 
their duration of anterograde movement in both axons and dendrites at later stages of 
development. Significant differences in the distributions of anterograde durations were 
found for days 4 vs. 12 (p < 0.0007), and between days 7 and 12 (p < 0.0001) in axons. 
No significant differences were found in the dendrites. Unlike mRNA, though, in the 
retrograde direction, distributions of durations of moving mitochondrial mRNA particles 
differed in axons, with a leftward shift (shorter) at later time points (4 vs. 12, p < 0.0001, 
and 7 vs. 12 p < 0.001), and in dendrites between days 4 and 12 (p < 0.02). 
Net velocity: The net velocity of mitochondria illustrated a different pattern from 
mRNA. In axons, net velocity was retrograde at days 4 and 7, before increasing 
anterogradely at day 12 (Fig 15c). Net velocity also increased over time in dendrites, 
though in this case a retrograde net velocity was observed at day 4 before changing 
direction and increasing in magnitude at days 7 and 12, resulting in significant 
differences among all three days (Fig 15d). 
 
Section 4: Discussion 
This work exploited high-resolution imaging, image-processing, and analytical 
tools to generate a comprehensive quantitative assessment of mRNA transport in axons 
and dendrites of cultured hippocampal neurons at different stages of maturity. This 
quantitative approach enabled us to extend previous literature on mRNA transport 
through the identification and characterization of two distinct classes of non-
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mitochondrial mRNA, which appear to differ in mRNA content as well as transport 
characteristics. Our data also indicated interesting differences between mRNA transport 
in axons and dendrites, enabling us to propose intriguing hypotheses regarding varying 
roles for mRNA transport in neurites of different polarity and physiological function. 
These results provide a baseline for future work to uncover mechanisms involved in the 
coupling of mRNA transport to local translation. 
Though the emphasis of this work was to provide new insights on mRNA 
transport, our concurrent analysis of mitochondria served multiple purposes.  First, co-
labeling mitochondria enabled us to distinguish between mitochondrial and non-
mitochondrial mRNA, allowing greater clarity in interpreting previous studies that used 
general mRNA markers. Second, the fact that transport profiles of mRNA were distinct 
from those of mitochondria provided internal validation for the absence of global effects 
such as toxicity or changes in cellular geometry that would identically influence all 
cargoes. Third, we were able to confirm and extend previous quantitative analyses of 
mitochondrial transport in our cultured rat hippocampal model.  Results and discussion 
pertinent to analysis of mitochondrial transport are presented as supplementary material 
(Fig 14 and 15). 
Subsection 1: Transport profiles differ in bright versus dim populations of mRNA 
 Several research groups have studied the axonal and dendritic distributions of 
mRNA and local protein synthetic machinery [69,70,71]. However, details on the role of 
transport in achieving these distributions are less prevalent. Our quantitative 
characterization of mRNA transport builds on literature that has examined various 
aspects of neuronal mRNA transport, both qualitatively and quantitatively.  
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Brightly fluorescent particles of slowly moving mRNA exist in both axons and 
dendrites, and appear qualitatively similar to puncta identified as mRNA granules in 
previous studies on mRNA localization and transport [68,72,73].  Net axonal and 
dendritic velocities, measured within a 15 minute imaging window and extrapolated to 
longer time periods, are consistent with slow bulk axonal transport (0.1-1mm/day), and in 
agreement with previous measurements of 0.5mm/day reported in dendrites in radiolabel 
pulse-chase experiments [74].  Maximum velocities, both anterogradely and retrogadely, 
are slightly lower in axons (0.03-0.06µm/sec), but agree exactly in dendrites (~0.09-
0.11µm/sec) with the value of 0.1µm/sec provided for motile mRNA granules in cortical 
neurites of unspecified polarity [68]. Minor differences in these values may result from 
developmental or physiological differences between our P1 neonatal hippocampal and 
published E18 cortical neurites. However, the likeliest source of discrepancy is the cutoff 
used to distinguish between stationary and motile puncta. With respect to the latter, our 
inclusion of particles with slow, but significant velocities at or above 0.001µm/sec could 
have lowered the average rate of transport compared to values previously reported [68]. 
The observation of a weakly fluorescent pool of rapidly moving mRNA was novel 
and surprising. Net velocities for dim particles were over two orders of magnitude higher 
than for bright particles. However, the weaker fluorescence implies a smaller quantity of 
mRNA, offsetting this apparent increase in net transport. Differences in fluorescence 
intensity and transport parameters suggest different modes of packaging and regulation of 
transport as well as possible differences in function.  
Because of the slow average velocities and our relatively low frame rate, it is not 
possible to infer the identity of motor proteins responsible for movement in either bright 
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or dim pools of mRNA. However, cell biological and biochemical studies have identified 
RNA granule association with KIF5 (kinesin-1) and KIF3 (kinesin-2) in dendrites, KIF3C 
in axons, and kinesin-1 and dynein in Drosophila S2 cells [75,76,77,78,79]. A role for 
microtubule-dependent motor proteins in transporting mRNA is also consistent with 
reductions in mRNA localization within neurites following microtubule destabilization 
with colchicine [68,80].  mRNA may also piggyback on ribosomes or other cargoes with 
which it has been reported to co-localize, including cytoskeletal elements such as actin 
[16,77,81].   
Varying functional roles for bright and dim particles can also not be inferred from 
our analysis. However, based on the increased mobility of this dim pool, one intriguing 
hypothesis is that dim particles reflect a pool of specific transcripts quickly recruited in 
response to an unexpected stimulus, such as injury, the termination of axonal outgrowth, 
or synaptic activity. This hypothesis is consistent with the trafficking of Arc mRNA, 
which encodes a protein believed to be involved in the maintenance of LTP. Synaptic 
activity triggers the transport of Arc mRNA to activated synaptic sites [82], and it 
accumulates near stimulated synapses on a time course that coincides with the duration of 
protein synthesis during LTP [83].  Such a role would contrast with a more general role 
for maintenance of cellular infrastructure during growth and homeostasis, which could be 
reflected in the larger, slower granules. Such posited differences are conceptually similar 
to differences in mitochondrial populations, which are often stationary along the axon, 
but are more mobile when recruited to areas of high demand, such as an extending 
growth cone (Miller and Sheetz, 2006). An alternate hypothesis is that larger, brighter 
particles represent a multicomponent granular complex, while dim particles represent 
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particles that are not yet incorporated into a substantial protein synthetic complex or 
smaller, more specialized translational entities. These hypotheses should be addressed in 
future studies that elucidate the identity of specific transcripts and components of the 
translational machinery that are transported in each pool. 
Subsection 2: mRNA transport profiles differ in axons and dendrites 
We identified several interesting differences in mRNA transport between axons 
and dendrites at varying stages of neurite maturity, in both bright and dim populations. 
Net velocities within a given neurite represent the combined influences of run velocities, 
net directionality, and the duration of movement of individual particles; thus, it was 
possible to identify the particular parameter or parameters responsible for any differences 
across experimental groups. For bright particles in axons, net velocities peaked at day 7 
before falling again at day 12. This net positive effect stemmed primarily from increased 
velocity and an increased proportion of anterogradely moving particles on day 7 
compared to days 4 and 12 (Fig. 12a and Fig. 13a). The subsequent reduction in net 
anterograde velocity at day 12 resulted from a slight decrease in anterograde velocity and 
an increase in stationary particles, at the expense of particles moving both anterogradely 
and retrogradely. These transport patterns were different from those of bright mRNA 
particles in dendrites, where net velocities were an order of magnitude smaller than in 
axons, and were retrograde at day 4 before changing directionality by day 12. This 
pattern was a result of a sharp transition from a predominantly retrograde pool of moving 
particles at day 4 to an anterograde pool by day 12 (Fig 10b). In contrast to bright 
particles, dim particles had comparable net velocities in both axons and dendrites that 
were up to two orders of magnitude higher than those of bright particles in either type of 
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neurite. Also in contrast to bright particles, the net velocities of dim particles increased 
dramatically between day 4 and 7 (Fig 11c), coinciding with the timeline for synapse 
formation and stabilization (Fig 1).  
In comparing transport timelines in axons versus dendrites, the relative increase in 
net axonal mRNA velocity at an earlier time point compared to dendrites supports a 
model where local translation initially contributes to synapse stabilization pre-
synaptically. Indeed, the observed increase in the net axonal velocity of bright and dim 
mRNA particles at day 7 coincides with the end stages of neurite outgrowth and the 
initial stages of synapse formation and stabilization (Fig 1, [64,65]). Such a timeline is 
also consistent with reported relationships between local translation and the effectiveness 
of neurotrophic signaling both during axonal outgrowth and pre-synaptic signaling 
[84,85].  Most notably, protein synthesis in both the axon and dendrites is required for 
effective axonal guidance by brain-derived neurotrophic factor (BDNF) and 
neurotrophin-3 (NT-3) [4,86].  Neurotrophins may also initiate early stages of synaptic 
strengthening, as axonally synthesized BDNF has been implicated in potentiating 
transmitter secretion from nearby synapses [4].   
In contrast, net dendritic velocities of bright, slow mRNA particles illustrated a 
linear relationship between net velocities and the maturity of neurons, with the highest 
reported net velocities at day 12 coinciding with an increased duration of synaptic contact 
(Fig 11).  Increased and sustained dendritic mRNA transport at later time points is 
consistent with a role for local protein synthesis in the context of sustained synaptic 
connectivity for LTP, consolidation of long-term memory, and immunity versus long-
term depression [4,17,41,61,83,87,88,89,90].  Several locally synthesized proteins 
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relevant for such synaptic plasticity are candidates to be found in observed dendritic 
mRNA pools, including αCAMKII [91] and cytoplasmic polyadenylation element 
binding protein (CPEB), which upon increased translation, through its long-lasting 
transmissible conformation, serves to provide a “memory” of the synaptic stimulation 
[92].  
Subsection 3: Mitochondrial transport profiles in axons and dendrites 
Mitochondrial transport has been characterized extensively in neurons of both the 
PNS and CNS. The bulk of this work has been performed in chick sympathetic neurons 
(e.g., [93,94]), though at least two papers [66,95] have quantified mitochondrial transport 
in rat hippocampal neurons, and further, axons and dendrites. Consistent with these 
studies [66,95,96], we observed that individual mitochondria moved with both 
anterograde and retrograde net directionality in axons and dendrites. The total percentage 
of directionally moving mitochondria (Fig 14 a-d) was not significantly different in axons 
and dendrites, and slightly higher than the 20-40% previously observed [66,95,96], 
though this difference may be a result of our slightly lower cutoff for stationary particles 
(0.001µm/sec vs. 0.01 µm/sec). In axons, we observed that mitochondria initially 
demonstrated a slight retrograde net velocity at early stages of growth and synapse 
formation (days 4 and 7), and an increase in anterograde net velocity as neurons further 
matured (day 12). These changes were primarily a result of changes in the duration spent 
moving in a particular direction, rather than differences in the velocity or directionality of 
individual particles (Fig 14 e,f). In dendrites, mitochondria also displayed a slight 
retrograde net velocity at day 4 before reversing to a net anterograde velocity at days 7 
 
 58 
and 12. In this case, however, differences were a consequence of differing directionalities 
of individual particles across days (Fig 15d). 
The observed differences in mitochondrial transport at varying stages of axonal 
and dendritic maturity are consistent with previous suggestions that mitochondrial 
movement is dependent on both the stage of growth and position within a neurite 
[66,94,95,96].  The specific pattern, though, appears to be heavily dependent on energetic 
requirements within a particular experimental model. For example, our observed increase 
in anterograde transport with developmental maturity is opposite to that observed in 
sympathetic neurons [93,94], which showed net anterograde mitochondrial transport in 
growing axons, but net retrograde transport in halted axons. This could reflect 
mitochondrial recruitment for synaptic activity and cytoskeletal stabilization in stationary 
CNS neurites (Fig 1; [97,98]) but the lack of such recruitment in axons whose growth is 
truncated by a non-physiological barrier [94]. Mitochondrial transport is also likely to 
depend heavily on the localization of existing pools of mitochondria. For example, in 
PNS axons, the highest levels of directional movement occur in regions away from the 
growth cone [93,94], while a large pool of mitochondria already localizes to the distal 
axon and growth cone [94].  This is in contrast to our observations of mitochondria more 
or less evenly distributed along the axon.  
 
Section 5: Conclusions 
This work provides the first rigorous quantitative assessment of axonal and 
dendritic mRNA transport during central neuronal development. Significant differences 
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in transport parameters for individual and pooled particles at different stages of neuronal 
maturity emphasize the dynamic nature of transport at multiple levels. As suggested for 
other cargoes, including mitochondria [24,26,45,55,94,99], the dynamics of mRNA 
transport are likely to be driven by the functional demands of the cell. Future studies will 
uncover mechanisms initiating and regulating changes in mRNA transport as well as the 
identity of specific classes of transcripts that are subject to such regulation. Additionally, 
datasets of multiple mRNA and mitochondria transport parameters that we generated in 
this study will be essential for validating theoretical models of neuronal mRNA or 
mitochondrial transport. It is our belief that multi-disciplinary approaches spanning the 
computational and biological realms will yield tremendous progress in understanding 
pathways of local translation and its regulation in neuronal development, disease, and 
injury. 
 
Section 6: Methods 
 
Ethics statement: All animal protocols were approved by University of Maryland 
Institutional Animal Care and Use Committee (IACUC). 
 
Primary cell culture 
Hippocampi were dissected from one-day-old Sprague-Dawley rats and maintained in 
ice-cold HBSS (2) media (HBSS 500 mL, D glucose .4g, HEPES .834g, Penicillin 15 
mL).  They were then incubated with 0.05% DNase (1.4 M MgSO4, HBSS 100 %) and 
Mixture A (PBS 100%, DL-Cysteine HCL 1.6mM, BSA 3.7µM, D-glucose 34.6 mM, 
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Papin 21µM) for 30 minutes at 37°C under agitation at 100 rpm. Following trituration, 
cells were pelleted at 234 × g for 3 minutes before resuspension in growth media 
(Neurobasal media supplemented with 2% B-27).  Finally, cells were plated on coverslips 
coated with 1mg/ml polylysine at a density of 20,000 cells in 500 µL. All cells were 
maintained and imaged at 37°C and 5% Co2.  
 
Immunofluorescence 
Hippocampal cells were fixed with 4% paraformaldehyde in PBS for 10 minutes and 
rinsed with PBS three times. Following permeabilization with 0.2% Triton X-100 in PBS, 
the cells were blocked with 10% Fetal goat serum and 3 % BSA for 30 minutes.  A 
1:1000 dilution of SMI-31 (Abcam Inc., Cambridge, MA), 1:500 dilution of MAP2 
(Abcam Inc., Cambridge, MA), or 1:200 dilution of Synapsin I (Sigma-Aldrich Corp., St. 
Louis, MO) in BSA was applied for an hour at room temperature, followed by three 
washes in PBS.  Fluorescently labeled secondary antibody was applied subsequently for 1 
hr at 37°C, followed again by three washes in PBS.  Finally, coverslips were mounted on 
a slide in the presence of Vectashield (Vector Laboratories, Inc., Burlingame, CA).  For 
co-labeling with RNA, cells were incubated with 500nM of Syto after application of the 
secondary antibody. 
 
mRNA and mitochondrial labeling  
For mRNA labeling, 500 nM solution of RNASelect green fluorescent cell stain (Syto, 
Excitation 490 nm, Emission 530 nm) in cell media was prepared. This solution was pre-
warmed at 37°C prior to application and used immediately. The cells were incubated with 
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500µL of the 500 nM labeling solution for 20 minutes at 37°C. After this, cells were 
rinsed once with cell-culture medium. Mitochondria (Excitation 579nm, Emission 599 
nm) were labeled by incubating dissociated neurons in a 1:10,000 dilution of 
mitochondrial dye, MitoTracker Red for 10 minutes at 37°C, followed by rinsing with the 
cell-culture media.  The neurons were labeled on days 4,7, and 12.  The imaging was 
performed immediately after application of the probes.   
  
Fluorescence Microscopy 
Imaging was performed on an inverted TE-2000E microscope (Nikon, Melville, NY) 
outfitted with a Lumen-PRO2000 (Prior Scientific, Rockland, MA) illumination system 
and Chroma filters (Bellows Falls, VT. EPI: 488 nm, Emission 530 nm). Additionally, a 
custom built chamber (Precision Plastics, Beltsville, MD) maintained temperature, 
humidity, and CO2 levels during imaging. DIC and Fluorescence images were captured 
for 15 minutes every 15 seconds using a 40x objective with 200ms exposure time. DIC, 
Syto RNA (490nm excitation), and Mitotracker (570nm excitation) channels were 




After incubation with Syto, imaging and live imaging was performed as mentioned.  
Then, cells were fixed with 4% paraformaldehyde for 10 min. After fixation, cells were 
permeabilized with 0.5% Triton X-100 for 5 min and incubated with RNase A 10 µg/ml 
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in Tris-buffered solution and for 1 hr at 37°C. A second image was taken of the labeled 
cell, and the intensities of the two signals were compared.  
 
Image Analysis:  
Image analysis was performed either on MATLAB (MathWorks, Natick, MA) or ImageJ 
(NIH).  To analyze the movement of mitochondria and mRNA particles in the axon over 
time, a custom program was used to create kymographs from time lapse movies as 
previous described [100].  Trajectories of mRNA particles that did not overlap with those 
of MitoTracker were concluded to be mRNA particles. The likelihood of a false positive 
(i.e., a mitochondrial particle that was mistakenly identified as a non-mitochondrial 
particle) was very low, owing to the considerably brighter fluorescence intensity of 
MitoTracker compared to Syto. mRNA particles from non-mitochondrial mRNA 
particles were analyzed separately. A series of image processing steps was performed to 
confirm and better visualize dim mRNA particles (Fig S3).  First, the kymograph of 
interest was processed by iteratively overlaying 300 images of the same kymograph, 
which were made 50% transparent (Gnu Image Manipulation Program, 
http://www.gimp.org). Each overlay resulted in a slight increase in signal to noise ratio, 
allowing enhancement of dim signals. The resulting kymograph was then contrast 
enhanced or inverted to visualize the dim mRNA moving particle (ImageJ).  Finally, 
local contrast enhancement was performed on each particle. Contrast enhancement with a 
similar mask was performed on both regions of interest (ROI) and non-ROI regions, to 





For directionality analyses, the following sample sizes (numbers of neurons) for each 
category were used; bright mRNA particles in axons: day 4: N= 11, day 7: N = 10, day 
12: N = 11; bright mRNA particles in dendrites: day 4: N = 4, day 7: N = 5, day 12: N = 
6; dim mRNA particles in axons: day 4: N = 5, day 7: N = 8, day 12: N = 11; dim mRNA 
particles in dendrites: day 4: N = 3, day 7: N = 5, day 12: N = 6; mitochondria in axons: 
day 4: N = 11, day 7: N = 10, day 12: N= 11; and mitochondria in dendrites: day 4: N = 
4, day 7 N = 4, day 12: N = 6.  
In addition, for net velocity, velocity, and distribution analyses, following sample sizes 
(number of particles) for each category were used: bright mRNA particles in axons: day 
4: N = 34, day 7: N = 53, day 12: N = 52; bright mRNA particles in dendrites: day 4: N 
=11, day 7: N = 14, day 7: N = 27; dim mRNA particles in axons: day 4: N = 31, day 7: 
N = 66, day 12: N = 77; dim mRNA particles in dendrites: day 4: N = 25, day 7: N = 56, 
day 12: N = 39; mitochondria in axons: day 4: N = 69, day 7: N= 82, day 12: N = 88; 
mitochondria in dendrites: day 4: N = 35, day 7: N = 42, day 12: N = 52. 
 
Maximum and average velocity:  
Particles with an average velocity of greater than 0.001µm/sec in either direction 
(0.1mm/day) were classified as moving, based on minimum velocities measured in a 
previous study [74].  Moving particles were segregated and further analyzed. The 
maximum velocity in each direction for each particle was calculated.  In addition, the 




Directionality Analysis:  
Particles not scored as moving, as defined above, were considered stationary. Most 
moving particles spent the majority of their time (>80%) moving unidirectionally; 
however, a small fraction of particles changed directions multiple times during a 
trajectory. These wiggling particles were classified as moving bidirectionally if their net 
displacement was less than 0.001 µm.  
 
Duration of directional movement:  
Only particles considered moving, as defined above, were analyzed for this parameter. 
The cumulative duration that each particle moved during its entire trajectory was 
calculated for both the anterograde and retrograde direction.  
 
Net Velocity:  
The net velocity for each particle was calculated using the equation below. 
 
Net Velocity =  
 
where νa = average anterograde velocity, νr = average retrograde velocity, Ta = Time 
spent in the anterograde direction, Tr = Time spent in the retrograde direction.  Graphs of 





Means were compared using ANOVA followed by Tukey’s post hoc analysis. 
Distributions were compared using Kolmogrov-Smirnov Test. We have also performed 
multiple regressions, with net velocity as the dependent variable and velocity and 
duration as independent variables. All statistical analysis was performed using SAS 
software (Cary, NC).  
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Chapter 3: Mouse whole hippocampal explant culture system to 
study isolated axons 
 
Section 1: Abstract 
We have developed a novel mouse neonate whole-hippocampus explant culture 
system to study central neuronal survival and axonal gene and protein expression in the 
context of regeneration. The explant culture system enables axon-specific measurements 
without the need of additional equipment.  In this report, we detail our validation of this 
model, and implement it to characterize axonal outgrowth following initial explant 
harvest and a secondary axonal injury.  We also compare the advantages and limitations 
of this model with existing models.  
Section 2: Introduction 
Damaged axons of the central nervous system (CNS) regenerate poorly, for 
reasons that are still being understood.  Current studies have probed numerous outcomes 
in the context of regeneration, including neuronal survival, gene expression, alterations in 
the mechanical and chemical environments, and axonal outgrowth [101,102,103].  
Despite this progress, though, due to their unique size and polarity, it is often necessary to 
examine the response of axons independently of their cell bodies.  
Several experimental systems have been developed to spatially separate cell 
bodies and axons, to measure of a variety of axon-specific outcomes. A number of studies 
detail devices that physical separate axons and somata of cultured cells, allowing 
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incubation of each region in distinct cellular media [104,105,106].  These include larger 
Campenot chambers as well as micropatterned and microfluidic compartmental culture 
systems [21,105,106,107].  Microfluidic methods range from producing a PDMS stamp 
to pattern compartmentalized micro-channels on a glass cover slide [108,109,110,111] to 
fluid compartmentalization by hydrostatic pressure gradients [21].  These methods have 
been well-validated for examining peripheral neurons. Although some reports have 
demonstrated successful use with central neurons [21], shorter axonal processes in the 
CNS make their use more challenging.  From a practical standpoint, despite their 
efficacy, fabrication and troubleshooting of these systems may be complex, fabricated 
devices may not be reusable, and additional effort may be required to maintain sterility.   
Explant cultures in the absence of compartmentalization have also been used 
when tissue integrity and connectivity, physical and functional, is desired, but fluidic 
isolation of axons and cell bodies is not necessarily required [112].  Explants allow 
manipulation of intact tissues in highly controlled settings, and include whole explant 
tissue, slice, and fragments of tissue [112,113,114].  Whole explant culture systems, 
extensively deployed for PNS and spinal hemi-cord models [115,116] are convenient and 
more completely preserve structural and functional connectivity compared to slice and 
fragmented culture systems. While a novel Drosophila brain culture system was recently 
introduced to study axonal regeneration of lesioned neurons [117], in general, whole 
brain explants have been underutilized, likely due to limitations in gas and nutrient 
exchange. We have developed a mouse neonate whole-hippocampus explant culture 
system to study central neuronal survival and axonal gene and protein expression in the 
context of regeneration. In this report, we detail our validation of this model, and its 
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implementation to characterize axonal outgrowth following initial explant harvest and a 
secondary axonal injury.  We also compare the advantages and limitations of this model 
with existing models 
Section 3: Results 
Subsection 1: Whole explant culture system enables pure isolation of axons  
We harvested and cultured whole mouse hippocampal explants for seven days on 
either plastic culture dishes or on glass cover slips, with the lateral explant surface face-
up. A ~0.4 mm ring of migrating cells emerged from the explant periphery, beyond 
which long projections extended over a distance of several millimeters. We confirmed 
that these projections were axons by co-labeling phosphorylated neurofilaments (SMI-31, 
axonal marker) and MAP2A (dendritic marker) (Fig 1c). This labeling also confirmed 
structural integrity within the explant itself as well as appropriate morphology of cells 







Figure 3-1: Illustration of explant and tissue injury and purity of axons.  
(A) Schematic overview of tissue injury to the CA3 region of hippocampus explants. (B) Schematic 
presentation of axonal injury with a needle, injury was performed 2/3 distance away from the edge of 
the explant. (C) Panel shows CA3 region of the uninjured explant with axonal marker (SMI), 
dendritic marker (MAP2), and overlay of both (SMI and MAP2) respectively from top to bottom. (D) 
Panel shows undamaged CA3 region of hippocampus explant after 7 days in culture with axonal 
marker (SMI), dendritic marker (MAP2), and overlay of both (SMI and MAP2), showing regions of 
cell bodies. (E) Panel shows pure axonal region of hippocampus explant after 7 days in culture with 
axonal marker (SMI), dendritic marker (MAP2), and overlay of both (SMI and MAP2), with no 
dendritic region (green). RT-PCR and Immunoblots were performed to ascertain exclusive nature of 
axonal preparation (F) RT-PCR confirms presence of β-actin and absence of γ-acting values (there 
were some samples with Ct values of >37) in axonal culture and presence of both genes in the tissue 
lysate.  (G) Immunoblots illustrate presence of Neun in positive control (cell body + Axon 
preparation), and absence of Neun in axonal preparations, whereas GAPDH is present on both the 
axon and positive control samples. Values represent means ±  SEM. Bar is 75µm.  
 
To further assess the exclusive axonal nature of the preparation, as well as test the 
feasibility and utility of our system to perform gene expression and biochemical assays 
 
 71 
on axonal fractions, we performed PCR and Western blot analysis on collected axons and 
whole explant homogenate. We first compared levels of γ–actin mRNA, which resides 
only in the cell soma but is restricted from axons [118,119,120], between axon and 
explant fractions via RT-PCR (Fig 1f). We also compared levels of  β-actin mRNA, 
which is found both in the axon and cell body (Fig 1f).  As expected, the results indicate 
high γ-actin transcript levels in explant fractions, and no γ-actin levels in the axonal 
population, demonstrating the purity of hippocampal axonal preparation. High β-actin 
gene levels were found, though at differing levels, in both fractions, confirming our 
ability to measure and compare gene expression. We then performed Western blot 
analysis on the isolated axon population, probing for protein levels of a neuronal specific 
nuclear protein (Neun), which is only found in cell bodies and not in the processes.  
Consistent with immunolabeling and PCR results, Western-blotting results indicated 
presence of Neun in the whole lysate, but not in the axonal preparation (Fig 1g). 
Collectively, these results indicate that isolated axonal processes were not contaminated 
with protein from neuronal cell bodies. 
We then tested the amenability of explant cells to transfection. We lipid-
transfected cells with a plasmid encoding soluble GFP tagged with a nuclear localization 
signal. Numerous fluorescent cells were observed for each label within and beyond the 
explant (Fig 2a), and a live-dead assay confirmed high cell viability, even following 




Figure 3-2: Illustrates transfection as well as viability of the cells after 7 days in culture. 
(A) Panel shows transfected cells (NFAT-GFP, green) as well as stained nuclear dye(Hoechst, blue), 
last panel is overlay of both. Two parallel panels showing multiple and single cell transfected.   (B) 
Imaging after live/dead assay show presence of live cells (green). Bar is 75µm.  
 
Subsection 2: Use of hippocampal explant model to examine axonal response to injury 
Having validated axonal purity and cell viability, we next used our explant system 
to probe axonal response to two different types of injury. First, we crushed the presumed 
CA3 region of the explant at the time of culturing, simulating a traumatic injury to a 
region particularly affected by traumatic brain injury (Fig 3a).  We observed the axon 
growth of the damaged and undamaged tissue for six days (Fig 3b,d).  The axons from 
damaged tissue lagged in their initial growth rate but extended at a faster rate at later days 
compared to the control (Fig 3d). Two-way ANOVA (grouping factors: injury, time) 
 
 73 
revealed an interaction between injury and time (p<0.02) as well as a significant effect of 
time (p<0.0001) on growth rate. We then probed outgrowth of axons after transecting 
axons projecting from explants that were and were not crushed (Fig 3c,e,f).  Two-way 
ANOVA revealed no effect of crush or axonal transection on instantaneous velocity.  
However, there was a significant difference between the distributions of the instantaneous 




Figure 3-3: Rate of axonal outgrowth of hippocampus axons after tissue and axonal injury. 
(A) Injured CA3 region of the explant axonal marker (SMI), dendritic marker (MAP2), and overlay 
of both (SMI and MAP2) respectively from left to right (arrow = region of injury) at day 0. Fig 1C 
shows uninjured CA3 region at day 0.  (Panel shows damaged CA3 region of hippocampus explant 
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after 7 days in culture with axonal marker (SMI), dendritic marker (MAP2), and overlay of both 
(SMI and MAP2), (arrow = region of injury), this illustrates axonal growth over 7 days at the site of 
injury. Fig 1D shows uninjured CA3 region after 7 days in culture.  Figure (C) Bright-field image 
shows axons before and after injury. (D) Average velocity of axons over 6 days in culture for both the 
control (no tissue damage) and tissue damage. With tissue injury, there is an initial delay resulting in 
slower velocity. Two way Anova show interaction between Experimental group and days (p<0.02) 
resulting in significant difference between the days (p<0.0001), N (explants) = 2-5 and n (axons) = 20-
50 (E) Cumulative histogram showing distribution of instantaneous velocity of axons with and 
without transection injury as well as with and without tissue damage. Within the no tissue and no 
axon damage population, there was a leftward shift. The tissue damage with no axonal damage had 
significantly different distribution compared to the population of no tissue and axonal damage 
(p<0.01, K-S test). N= 3-6 (F) Average of instantaneous velocity shown in figure 3E. Values represent 
means ±  SEM.  Bar is 75µm.  
 
 
Section 4: Discussion 
We have characterized and validated in this study a novel whole explant culture 
system, to further investigate mechanisms associated with neuronal regeneration. Our 
initial application of this model was to investigate the differential response of axonal 
outgrowth following tissue or axonal injury. The results of this study highlight the ability 
to maintain cell viability in explants, perform high-resolution imaging on explants and 




Subsection 1: Comparison to other compartmentalization and explant models 
A variety of methods have been developed to examine the differential response of 
axons and neuronal cell bodies. Compartmentalization of dissociated neurons has been 
performed with a variety of devices, which separate axons and cell bodies and their 
incubating media with a physical or hydrostatic barrier [121,122]. Such devices are 
particularly effective for peripheral neurons, which possess the long axons required to 
pass the barrier in sufficient number. Hydrostatic compartmentalization has also been 
used to effectively separate central axons from their cell bodies, enabling high-resolution 
axonal imaging [21].  However, the small numbers of axons that are compartmentalized 
make such a strategy inefficient for axonal biochemistry or transcriptional analysis. In 
addition, the variability and ambiguity in axonal orientation of dissociated cells can 
confound interpretation of polarity-dependent processes (e.g., axonal transport) in 
dissociated culture systems. 
 
Slice and explant cultures offer the advantage of preserved structural and functional 
cellular connectivity, and also clear directionality of projections emanating from the 
tissue mass. Slices maintain neuronal connectivity in the plane of analysis, and also 
provide cellular accessibility for electrophysiological measurements. However, out-of-
plane connectivity is compromised, with particular damage to cells at the edge-planes of 
slices. In contrast, whole explants provide three-dimensional connectivity of cells within 
the explant, and a more physiological cellular environment with respect to localization 
and mechanical environment of supporting cells. DRG explants are an especially popular 
experimental model for the PNS [123]. Spinal cord explants, including ventral roots as 
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well as hemi-cord explants have also been used, and straddle the PNS and CNS 
[113,114,124,125,126,127].  
Whole explants for the brain or its sub-domains are used less frequently, though a 
recent in vitro Drosophila brain explant culturing system demonstrated the value of such 
a system [117].  We implemented a conceptually similar whole explant culture system, 
and confirmed explant viability and axonal outgrowth from the explant over at least 
seven days.  In addition, we were able to harvest and analyze purified axon fractions 
using PCR and Western blotting. Thus, for applications that do not require separation of 
culture media, we have developed a simple method, which does not require specialized 
equipment or tools, to analyze the activity of well-aligned, predictably oriented axons 
decoupled from that of cell-bodies. While culture of hippocampi from mouse genetic 
models, of which there are many, is in itself of value, the ability to transfect cells further 
enhances its utility in dissecting mechanistic pathways for injury and repair. 
It is important to note that our methodology too has its limitations. Viability is 
likely restricted in part by the size/thickness of explant, which correlates with the 
efficiency of nutrient exchange with incubating media; hence, we speculate that our 
system may be restricted to a scale comparable to that of embryonic or neonatal rodent 
tissue. Thus, as for other culture models, this may confound the ability to perform 
experiments requiring an adult model. Finally, in contrast to slice models, though 
structural integrity is better maintained, targeting of a specific population of neurons for 
electrophysiological assessment may be more difficult due to overlying tissue 
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Subsection 2: Influences of primary and secondary injury on axonal outgrowth 
In the PNS and spinal cord, previous studies have demonstrated that conditioning 
lesions (secondary injury) enhance axonal regeneration, either by reducing the initial lag 
in outgrowth or by increasing the initial rate of axonal outgrowth [128,129].  We 
therefore tested, using two types of injury, whether a conditioning lesion influenced 
neuronal outgrowth in neurons from brain. Our results suggest that tissue crush initially 
delays axonal outgrowth, but there is no change to overall length over six days. It is likely 
that the damage to the tissue injures resident cells and causes damage causing initial lag 
in axonal outgrowth [130]. Although no direct comparison can be made given differences 
in the model system, a comparison with axonal outgrowth rates in slice culture models 
indicates a similar range of axonal outgrowth rate (0.01 -0.6 mm/day) [131,132].   
Axotomy, with or without the initial crush, allowed evaluation of instantaneous 
velocities at the site of injury. These velocities were unaltered up to 1 hour post-injury, 
irrespective of experimental group.  Future experiments should be performed to measure 
velocities at later time points or following different lags following crush injury. For 
example, secondary injury was performed within two days of first injury, whereas it is 
typical to wait seven days before the second injury.  Also, the hippocampal excision itself 
may have created a primary lesion to some neurons that ultimately extended beyond the 
explant. Thus, crush injury may in fact be a secondary lesion, and axonal severing either 
a secondary lesion (no crush) or even a tertiary lesion (with crush).  
Section 5: Conclusions 
We have characterized and validated a novel hippocampal whole explant model. We have 
also demonstrated the feasibility of probing axonal biology, biochemistry, and extension 
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free from confounding effects of neuronal cell bodies. Recent literature in the peripheral 
nervous system has elucidated many details regarding pathways by which local axonal 
response influences neuronal regeneration. Our model may be particularly useful in 
probing similar mechanistic questions in central axons. We anticipate that the simplicity 
of our experimental system will provide a versatile tool, amenable to genetic and 
pharmacological manipulation, to probe multiple aspects of neuronal injury and 
regeneration. 
 
Section 6: Methods 
Ethics statement: All animal protocols were approved by the University of Maryland 
Institutional Animal Care and Use Committee (IACUC). 
 
Dissection and explant culture: C57/Black 6 mouse neonates (P1) were euthanized. 
Brains were harvested and maintained in cold Hank's Balanced Salt Solution (HBSS) 
(HBSS 500 mL, D glucose .4g, HEPES .834g, and Penicillin 15 mL).  Curved forceps 
were used to split the left and right hemispheres of the brain, meninges carefully 
removed, and hippocampus detached from surrounding tissue and maintained in ice cold 
HBSS (2).  For explant culture, the hippocampus was placed on a ~0.2 µL drop of 
Matrigel on lysine (1mg/ml)-coated glass cover slips.  An additional 0.2 µL of matrigel 
was introduced to the underside of the explant as needed with a micropipette, to further 
secure the explant to the substrate. After 30 minutes incubation, culture media 
(Neurobasal media supplemented with 2% B-27) was added.  Media was changed 
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carefully every 3 days, so as not to dislodge the explant. All cells were maintained at 
37°C and 5% CO2. Detached explants or fragmented hippocampi were discarded. 
 
Tissue injury and axonal outgrowth: At the time of plating, explants were either plated 
immediately or after crushing the presumed CA3 region with forceps (Fig 1a). Axons 
were allowed to grow out from the explant for six days. Axonal outgrowth was measured 
every 1, 3, & 6 days after plating using Image J, from images captured using an inverted 
TE-2000E microscope (Nikon, Melville, NY; described below). 
 
Axonal injury and instantaneous outgrowth: Uncrushed and crushed explants were 
allowed to grow for two days, after which axons were severed with a 30-gauge needle at 
a 2/3 distance away from the explant edge (Fig 1b). After transection, time-lapse imaging 
(every 5 minutes for 1 hour) of axonal outgrowth was captured with an inverted TE-
2000E microscope (Nikon, Melville, NY).  The instantaneous velocity was measured 
using Manual Tracking in Image J.    
 
Axon Isolation: Explants were allowed to grow for seven days. Injured (as above) or non-
injured axons were collected using appropriate lysis buffer and a micropipette through 
careful observation under a light microscope.  To avoid any cell body and dendritic 
contamination, we avoided regions at the explant edge. For severed axons, tissue was 
collected both proximal and distal to the injury site, to enable comparison with 
corresponding control axons. We performed additional analysis on each sample to assess 
the exclusive axonal nature of the preparation. For gene expression assays, we probed the 
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absence of γ–actin mRNA by PCR, which resides only in the soma but is restricted from 
axons [118,119,120].  For protein assays, we probed the absence of Neun, a neuron-
specific nuclear, and thus axon-excluded, protein by immunoblotting [133].  
 
PCR: For detection of axonal transcripts, ~ 100 ng of RNA from axons was used as a 
template for reverse transcription (RT) with M-MLV Reverse Transcriptase 
(RT)(Invitrogen, Carlsbad, CA) and an oligo (dT) primer at 90°C for 1 h. The RT 
reactions were diluted 10-fold and used for transcript-specific PCR. To select primer 
sequences, we used Primer 3, based on nucleotide sequences found on the NCBI mouse 
genome browser.  Primer sequences used for PCR are provided in Table 1. Negative 
controls were performed on each sample, and consisted of RNA processed without the 
addition of RT, or water controls (no DNA). For quantitative RT-PCR, the control and 
sample RT reactions above were amplified using the Thermocycler detection system 
(Bio-Rad, Hercules, CA). These reactions were performed using the Soo Fast Green Eva 
Mix Master Mix (Bio-rad, Hercules, CA) for all transcripts. All control and samples were 
assayed in triplicate for four independent experiments. Thermal cycling was initiated with 
an initial denaturation at 50°C for 2 min and 95°C for 10 min followed by 40 cycles at 
95°C for 15 s and 60°C for 1 min.  Ct values for each transcript were determined using 
the automatic Ct algorithm of the My IQ software to calculate the optimal baseline range 
and threshold values. Any samples indicating amplification of the γ-Actin transcript were 
discarded. 
 
Genes Primers Forward Primers Reverse  
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β-Actin ccaccatgtacccaggcatt agggtgtaaaacgcagctca 






Transfection: Explants were transfected with Effectene Transfection reagent 
(Qiagen,Valencia, CA), according to manufacturer’s instructions.  All transfections took 
place in Neurobasal supplemented with 2% B-27.  Explants were washed 12 hrs after 
transfection.   
 
Live/dead assay: After transfection, cultures were washed three times. Cell viability was 
assessed using Live/Dead reagent (Invitrogen, Grand Island, NY). Manufacturer's 
protocol was followed. Briefly, 10 uL of 2mM Eth-D-1 was added to 5 mL of PBS. Then, 
2.5 uL of Calcein AM was added to the solution. Then, about 500 uL of the solution was 
added to the Explants. Explants were incubated for 22 minutes, washed, and imaged via 
inverted TE-2000E microscope (Nikon, Melville, NY).   
 
Immunofluorescence: Hippocampal explants were fixed with 4% paraformaldehyde in 
PBS for 10 minutes and rinsed with PBS three times. Following permeabilization with 
0.2% Triton X-100 in PBS, the cells were blocked with 10% Fetal goat serum and 3 % 
BSA for 30 minutes.  A 1:1000 dilution of SMI-31 (Abcam Inc., Cambridge, MA), 1:500 
dilution of MAP2 (Abcam Inc., Cambridge, MA) in BSA was applied for an hour at room 
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temperature, followed by three washes in PBS.  Fluorescently labeled secondary antibody 
was applied subsequently for 1 hr at 37°C, followed again by three washes in PBS.  
Finally, explants were imaged using a Leica SP5X confocal microscope. 
 
 
Immunoblotting: Axon samples and positive control (whole explant) samples were lysed 
using NP40 lysis buffer mixed with protease inhibitor (Fisher-Scientific, Houston, TX) 
and phosphatase inhibitor (Roche Diagnostics, Indianapolis, IN, USA). The homogenate 
was further lysed using liquid nitrogen, and supernatant was stored at -80ºC.  Protein 
concentration was measured using a bicinchoninic acid protein assay kit (Pierce; Thermo 
Fisher Scientific, Rockford, IL, USA). An equal amount of the protein (60 µg) was 
loaded into each lane, run on 4- 15% Mini-Protean Precast gel (Bio-rad,Hercules, CA ), 
and transferred to PVDF membranes (Millipore, MA). Membranes were blocked 
overnight using casein-blocking buffer (Vector Lab, Burlingame, CA), and then 
incubated for 2 h at RT either with GAPDH (diluted 1:60000, Fitzgerald, Acton, MA) or, 
Neun (diluted 1:500, Millipore, Billerica, MA).  Appropriate secondary antibodies, and 
DuoLux Chemiluminescent was used for detection following protocol given in 
Vectastain-AMC Amp kit (Vector Lab, Burlingame, CA). The membranes were detected 
using ChemiDoc™ XRS+ (Bio-rad, Hercules, CA), and analyzed using Image Lab 
software (Bio-rad, Hercules, CA). All data is presented normalized to GAPDH.  
Experiments were repeated at least three times. All samples were imaged for observance 




Fluorescence Microscopy: Imaging was performed on an inverted TE-2000E microscope 
(Nikon, Melville, NY) outfitted with a Lumen-PRO2000 (Prior Scientific, Rockland, 
MA) illumination system and Chroma filters (Bellows Falls, VT. EPI: 488 nm, Emission 
530 nm). Additionally, a custom built chamber (Precision Plastics, Beltsville, MD) 
maintained temperature, humidity, and CO2 levels during imaging. Live imaging for 
axonal outgrowth analysis was performed using DIC. Images were captured for 60 
minutes every 5 minutes using a 40x objective. Leica SP5X confocal microscope was 
used for explant imaging; they were either imaged using a 10x or 40x objective with 




Two-way analysis of variance (ANOVA) was performed to measure axonal outgrowth 
rate over days. Kolmogorov-Smirnov (K-S) test was performed to compare distributions.  
For all comparisons, we used 3- 6 independent explants and 20-50 axons for analysis. All 
data are presented as mean ± standard error.  Distributions are presented as a cumulative 





Chapter 4: Biphasic increase of retrograde injury signaling 
complex-related genes in central axons following injury 
Section 1: Abstract 
Axonal injury activates several programs to promote neuronal survival and axonal 
regeneration.  One such response is retrograde injury signaling (RIS), which promotes 
local axonal protein synthesis (LPS) and enhances neuronal regeneration in the peripheral 
nervous system (PNS). RIS is also initiated following injury of neurons in the central 
nervous system (CNS).  However, it remains unknown how the localization of axonal 
mRNA required for LPS is regulated. We used a novel whole hippocampal explant 
system to examine mechanisms influencing changes in axonal levels of RIS-associated 
genes and proteins following axonal injury. Axonal levels of several transcripts, 
including importin β1 and RanBP1, were elevated biphasically at 1 and 24 hrs post-
axotomy.  Transcript levels for β-actin, a prototypic locally synthesized protein, were 
similarly elevated.  Our data suggest that axonal transcript levels are regulated differently 
for different genes. At 1 hr post-injury, experiments performed in the presence of 
actinomycin indicated that RanBP1, but not importin β1, requires de novo mRNA 
synthesis. At 24 hrs post-injury, experiments performed following importazole treatment 
indicated that the second wave of increased axonal mRNA levels required importin β 
mediated nuclear import.  Consistent with studies in the PNS, we observed increased 
importin β1 (90%) axonal protein levels at 6hrs post-injury. Unlike in the PNS, though, 
we observed reduced RanBP1 levels (60%) at 3 hrs and vimentin levels (50%) at 3 and 6 
hrs post-injury.  This study revealed temporally complex regulation of axonal gene 
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expression, and has significant implications for our understanding of neuronal response to 
injury in the CNS.  
Section 2: Introduction 
The poor regenerative capability of the central nervous system (CNS), compared 
to the peripheral nervous system (PNS), limits recovery from a number of traumatic and 
degenerative conditions. On the other hand, central neuro-regeneration has been observed 
in limited contexts (e.g., [9,11]), indicating a need to better understand mechanisms 
underlying regenerative capacity.  
A key advance in understanding mechanisms underlying the robustness of PNS 
regeneration was the identification and characterization of the retrograde injury signaling 
(RIS) pathway, which requires transport of injury signals from the injury site to the cell 
body. Details of this pathway in the PNS have been well summarized in several reviews 
[36,47,51,54,55]. Briefly, rapid ion influx at the injury site generates a rapid response that 
propagates retrogradely to provide the first indication of lesion events [47,48,49,134].  A 
slower component of RIS results in increased dynein-dependent transport of an injury-
induced signaling complex from the site of injury to the nucleus [47,50,51].  Importantly, 
injury also induces local axonal translation of several proteins required for RIS complex 
transport, including importin β1, RanBP1, and vimentin [36,47,51,52,53,55]. 
 Importin β1, among its diverse roles [135,136,137,138], is a key node in RIS 
pathways, as its knockout attenuates transcriptional responses to nerve injury and delays 
functional recovery in vivo [54].  Interestingly, recent evidence suggests that importin β1 
may also play a role in central neuronal regeneration. Ohara and colleagues indicated that 
importin β1-associated STAT3 signaling molecules were transported retrogradely after 
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injury of hippocampal neurons, but only when importin-STAT association was intact 
[56,57].   
 Despite these compelling advances, several key gaps remain in understanding RIS 
mechanisms.  A key unknown in both the PNS and CNS is whether and by what 
mechanisms transcriptional levels of RIS associated genes are altered locally in the axon 
in response to injury.  Additionally, in the CNS, it has not yet been tested whether 
importin β1 and other proteins associated with importin in the PNS, including RanBP1 
and vimentin, are translated. The goals of this study were to further unveil importin β1-
dependent RIS mechanisms in the CNS, through the use of a novel hippocampal explant 
system, which enabled examination of axonal gene and protein expression independent of 
neuronal cell bodies.  Our results suggest a biphasic axonal response, in which levels of 
several axonal transcripts, including those associated with RIS, increase rapidly in axons 
after injury, contributing to early synthesis of corresponding proteins. Importin β1-
dependent activity at the nucleus then appears to modulate a second wave of RIS-
associated transcripts, which are likely to further support axonal outgrowth.  
Section 3: Results 
Subsection 1: Whole explant model for examining isolated hippocampal axons 
To examine the axonal expression and regulation of genes involved in CNS RIS, 
we developed a novel hippocampal mouse whole explant system, which enabled injury 
and analysis of isolated axons.  For this study, we cultured P1 explants for seven days, 
and cut the axons on the seventh day to study axonal response to injury at time points up 
to 24 hours [Fig 1a,b].  Uninjured axons at the same time point were used as controls. 
Immunofluorescence evaluation of an axonal marker, phosphorylated neurofilament 
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[SMI-31], and a dendritic marker, microtubule-associated protein 2 [Map-2A], confirmed 
the axonal nature of long projections from the explant [Fig 1c; cf. Chapter 3]. In addition, 
the exclusion of nuclear or cell body markers was assessed in the axonal lysate of each 





Figure 4-1: Illustrating axonal injury and exclusive nature of axonal preparation.  
(A) Schematic presentation of axonal injury with a needle, injury was performed 2/3 of distance 
away from the edge of the explant. (B) Bright-field image illustrating before and after axonal injury.  
Hippocampal explants are differentiated and present distinct morphology for both the axons and 
dendrites. Dendrites have shorter process and taper more gradually, while axons display a long, 
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narrow process with minimal tapering (C) Double-label immunofluorescence of SMI-31 (red) and 
MAP2 (green), showing presence of axonal outgrowth, and very few or no dendrites proximal to the 
tissue (green non-specific binding). Arrow indicate direction of growth.  RT-PCR and Immunoblots 
were performed to ascertain exclusive nature of axonal preparation (D) RT-PCR confirms higher 
levels of genes in the whole tissue compared to only axons validating the presence of for importin β1, 
RanBP1, Vimentin, β-actin, and γ-actin in whole tissue (positive control).As well as, it confirms 
presence of β-actin and absence of γ-acting values (there were some samples with Ct values of >37).  
Bar is 75µm  
 
Subsection 2: Influence of axotomy on axonal mRNA expression 
Based on the retrograde transport of RIS signaling complexes observed in both 
the PNS and CNS [36,47,51,52,56,57], we hypothesized that levels of genes encoding 
RIS complex components too would be increased in axons. To test this hypothesis, we 
first performed RT-PCR at 1, 6, 15 and 24 hrs post-injury.  Injury caused a significant 
increase in axonal levels of importin β1 (2.82 1.7, 4.5; p<0.002) and RanBP1 
(2.70 1.5, 4.9; p<0.009), but not vimentin (p=0.46), 1 hr after axotomy relative to 
control (no injury).  Transcripts encoding β-actin, which is a well-described locally 
synthesized protein not believed to play a role in RIS, also significantly increased 1 hour 
after axotomy compared to controls (4.73 2.1,10.6; p<0.003), serving as a “positive 
control” [Fig 2].  Axonal levels of all four genes were not significantly different between 
injured and uninjured axons 6 – 15 hours after axotomy (p>.05).  Interestingly, 24 hrs 
after axotomy, we observed a second wave of significantly increased levels of importin 
β1 (2.74 0.7, 10.6; p<0.06), and RanBP1 (2.48 0.8, 7.5; p<0.05) mRNA compared to 
controls.  β-actin mRNA levels also trended higher at 24 hours (p=0.45), but differences 
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with controls did not reach statistical significance [Fig 2].  These results thus suggest a 
biphasic elevation in key RIS-associated genes associated with nuclear import. 
 
 
Figure 4-2: Real-time RT-PCR was used to quantitate levels of specific mRNAs in the axonal RNA 
samples post axotomy.   
Results for importin β1, RanBP1, vimentin, and β-actin are illustrated. All values are displayed 
relative to no injury to axons as a control.  Specifically, at 1 hr after axotomy, there is a significant 
increase in importin Beta, RanBP1, and β-actin mRNA levels. The levels are suppressed at 6 and 15 
hrs after axotomy. The levels increase again at 24 hours for importin β1 and RanBP1. No significant 
changes were observed in vimentin transcript levels.  Error bars represent the SD of three - four 
independent experiments. Significance was calculated based on P ≤ 0.05 by pair wise fixed 




Subsection 3: Influence of transcriptional inhibition on axonal mRNA expression 
The above results support the hypothesis that an injury-induced signal causes 
elevation in axonal levels of importin β1, RanBP1, and β-actin at an early stage, within 1 
hr after axotomy.  We next assessed whether this increase in gene levels required de novo 
transcription, in the cell body.  We used the well-characterized antibiotic actinomycin D 
(AMD) to inhibit transcription, and performed RT-PCR to measure changes in gene 
expression at 1 hr post-injury.  To identify conditions under which AMD inhibited 
transcription in our culture system, we examined total mRNA content in response to a 
range of times.  A dose of 5 mg/mL of AMD for two hours resulted in ~50% total 
transcript reduction, which we deemed sufficient to block transcription.  AMD treatment 
suppressed the injury-induced increase in mRNA levels of RanBP1 (0.98 0.34, 2.74) 
and β-actin (1.29 0.42, 3.79) observed in untreated cells, suggesting that these genes 
were newly transcribed and rapidly recruited to axons. However, surprisingly, AMD 
treatment did not inhibit the injury-induced increase in axonal importin β1 mRNA levels 
(2.64 0.60, 11.5; p<0.001). These results suggest that increased axonal importin β1 
transcript levels reflect contributions from pre-existing transcript populations in the cell 
body or axons proximal to harvest level [Fig 3]. 
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Figure 4-3: RT-PCR was used to measure levels of axonal mRNA in injured hippocampal axons after 
inhibiting transcription relative to control (uninjured axons).  
The results indicate significant elevated mRNA levels in importin β1, suggesting a transport of pre-
existing mRNAs from the cell body. The levels of RanBP1, vimentin and β-actin are down-regulated, 
suggesting a requirement of newly synthesized mRNAs upon injury [white bar]. Comparison of no 
actinomycin treated injured with respect to control data (previously graphed Figure 2, 1hr) depicts 
suppression of Ranbp1, vimentin, and β-actin levels after the AMD treatment [black bar].  Error 
bars represent the SD of three-four experiments. Significance was calculated based on P ≤ 0.05 by 
pair wise fixed reallocation randomization test compared with the control. 
 
Subsection 4: Influence of axotomy on axonal protein levels 
To test whether and over what time frame early increases in transcript levels 
ultimately resulted in changes in protein expression, and thus the possible formation of 
RIS, we explored changes in axonal levels of RIS proteins in response to injury. We 
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evaluated the expression of importin β1, RanBP1, and vimentin at 0hr, 1hr, 3 hr, and 6 hr 
after axotomy.  As was also the case for mRNA levels, each RIS protein responded 
uniquely to injury. Consistent with local axonal translation (though not excluding some 
contribution from the cell body), importin β1 levels increased continuously during the 6 
hour observation period, with a significant increase at 6 hr after axotomy (90% increase, 
p<0.05) [Fig 4c,a].  Conversely, Ranbp1 protein levels (60% reduction p<0.05) decreased 
at 3 hours compared to the baseline level (control), but rebounded by 6 hrs [Fig 4d,a].  
Vimentin protein levels were significantly reduced at 6 hr after axotomy (50% reduction, 
p<0.05) [Fig 4e,a].  Thus, despite some variability in the temporal coupling between 






Figure 4-4: Western blot analysis of lysates from axotomized hippocampal explants axons from 0 min 
to 6 h after axotomy.  
(A) Illustrates blots of each protein normalized to GAPDH. (B) Illustrates exclusion of Neun protein 
from axonal population with respect to GAPDH blot. (C) The graph shows increase in importin β1 
axonal protein levels 6 hours after axotomy (D) The graph shows significant decrease in RanBP1 
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levels 3 hr after axotomy, increases back at 6 hrs post- injury.  (E) Vimentin level decrease at 3 and 6 
h post axotomy. Data are represented as the percent change in protein levels compared to control 
(uninjured axons) ± SE of three - seven independent experiments compared with the control 
(Student’s t-test, p ≤ 0.05).   
Subsection 5: Influence of importin β mediated nuclear import on axonal mRNA 
expression 
Having established an increase in both importin β transcript at 1 hour and protein 
at 6 hours, we next tested whether importin β1-mediated nuclear import was required to 
transcribe new importin β, RanBP1, and β-actin mRNA observed in the second phase of 
increased gene expression at 24 hrs.  To minimize non-specific perturbation of the 
diverse functional roles of importin β1, we specifically disrupted nuclear import mediated 
via importin β using importazole (IPZ). IPZ's role in disrupting importin β mediated 
nuclear import in non-neuronal cells was extensively characterized by Soderholm et al 
[139].  However, IPZ inhibition of nuclear import in an explant system, and specifically 
in neurons, has not yet been characterized. We therefore tracking the localization of the 
transcription factor NFAT fused to GFP (NFAT-GFP) in response to IPZ treatment. 
Studies in non-neuronal cells reveal that NFAT-GFP shuttles between the nucleus and 
cytoplasm in calcium regulated manner, and is imported by importin α/β and exported by 
CRM1 [140,141,142,143].  As expected, at steady state, NFAT-GFP was predominately 
cytoplasmic in cells within and at the edge of the explant. Also, as expected, an increase 
in cytoplasmic calcium induced by ionomycin led to accumulation of NFAT-GFP in the 
nucleus [Fig 5a].   
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Explants were then treated with 18µm importazole for 24h hours followed by 1.5 
hr treatment of ionomycin in the continued presence of importazole. In stark contrast to 
control cells, there was no import of NFAT-GFP in importazole treated cells (Fig 5b,c); 
specifically, IPZ treatment resulted in nuclear exclusion of NFAT-GFP in 75% cells after 
12 hrs (p< 0.015), and 86% cells after 24 hrs (p<0.003) (Fig 5c) demonstrating 
effectiveness of IPZ. Because explants contain both neuronal and non-neuronal cells, we 
also used immunofluorescence with SMI-31 (axonal marker) to verify that IPZ 
successfully inhibited nuclear import in neuronal cells [Fig 5d].  Importantly, 
transfection, importazole and ionomycin treatment caused minimal cytotoxicity.  
Following IPZ and ionomycin treatment of cells expressing NFAT-GFP, we performed a 
live/dead assay, which indicated over 86-91% survival of cells treated with DMSO 
(control), as well as transfected cells treated with IPZ followed by ionomycin treatment 







Figure 4-5: Importazole bocks Importin beta-mediated nuclear import in hippocampal explant.  
(A) Cells stably expressing NFAT-GFP were not-treated with importazole prior to a 1.5 hr treatment 
with ionomycin to induce nuclear import of NFAT-GFP. Presence of nuclear localized GFP signal 
indicate expression within nucleus, NFAT-GFP illustrates signal within nucleus (Hoechst, arrows) 
and surrounding regions (overlay, arrows) (Inset – expanded for more clear visualization). (B) Cells 
stably expressing NFAT-GFP were treated with 18uM of importazole for 24 hours prior to a 2 hr 
treatment with ionomycin to induce nuclear import of NFAT-GFP. Absence of nuclear localized GFP 
signal indicate exclusion of nuclear GFP signal, NFAT-GFP excluded from nucleus (Hoechst, arrows) 
and presence of GFP signal in cytoplasmic regions (overlay, arrows) (Inset – expanded for more clear 
visualization). (C) Results were quantified as the percentage of cells with nuclear NFAT-GFP N=2, 
150 or more cells counted under each conditions. The treatment blocks nuclear import in 75% of 
cells within 12 hrs, and 86% of cells within 24 hrs (Student’s t-test, p≤.05). (D) Cells expressing 
NFAT-GFP were immunostained for axonal marker (SMI-31- red) after IPZ treatment illustrate 
population of neuronal cells also affected by the IPZ treatment. Presence of GFP signal is observed in 
the proximal axons. Arrows indicate absence of GFP signal within in the nucleus. SMI-31 also labels 
the nucleus. (E) Live/dead assay of either control or treated (F) with IPZ and Ionomycin after 
transfection show no toxicity both in control and treated cells. Bar is 50µm. Values represent means 




We then evaluated changes in axonal mRNA levels 24 hrs post-injury followed by 
IPZ treatment.  IPZ treatment suppressed the second wave of increased axonal mRNA for 
all RIS-related genes and β-actin, as indicated by the lack of significant changes in 
axonal mRNA levels of all genes after IPZ treatment at 24 hrs post-injury relative to 
control [Fig 6].  When viewed in combination with the transcriptional and translational 
up regulation of several key RIS proteins at earlier time points, these results support a 
model whereby an RIS feedback mechanism is required for secondary amplification of 
both RIS-associated and unassociated mRNA at later time points.  
 
Figure 4-6: RT-PCR was used to measure levels of axonal mRNA in injured hippocampal axons after 
inhibiting nuclear transport relative to control (uninjured axons).  
The results indicate suppression of elevated mRNA levels in importin β1, RanBP1, vimentin and β-
actin  [white bar].  Comparison no IPZ treated injured with respect to control data (previously 
graphed Figure 2, 24 hr, light gray bar) clearly depicts suppression of gene levels after the IPZ 
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treatment.  Error bars represent the SD of three-four experiments. Significance was calculated based 
on P ≤ 0.05 by pair wise fixed reallocation randomization test compared with the control. 
 
Section 4: Discussion 
In this study, we examined axonal levels of RIS-associated genes, which will 
ultimately be translated to activate RIS pathways. Our findings suggest that axotomy 
results in biphasic elevation of axonal mRNA, at 1 and 24 hours after injury. Regulation 
of this biphasic response appears gene-specific at the early time point, with importin β 
mediated nuclear import required for the second wave of axonal gene expression.  
 
Subsection 1: Biphasic elevation in mRNA levels after axotomy 
Inhibition of protein synthesis in axons significantly impairs growth cone activity 
and axonal extension [28,46], emphasizing the importance of local protein synthesis for 
regeneration.  Among the many axonally synthesized proteins, translation of importin β1, 
RanBP1, and/or vimentin following axonal injury suggests a role for local protein 
synthesis in RIS. In particular, local translation of RanBP1 following injury results in 
RanGTP dissociation from importins, allowing binding of newly synthesized importin β 
to importin α and dynein-bound RIS complexes that are transported to neuronal cell 
bodies [36,47,53,57].   
To execute these retrograde signaling pathways, required transcripts must be in 
place beforehand, or must be rapidly recruited to the site of injury [21]. The rapid 
increase in mRNA transcripts within the axon implies rapid localization to the injury site 
[Fig 2].  This response is consistent with the rapid retrograde propagation of an 
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electrophysiological response, possibly mediated by calcium, which provides the first 
indication of a lesion even [47,48,49,50,51,144].  On the other hand, electrical activity 
alone is not sufficient to initiate regeneration [52,145], and thus our observed secondary 
elevation in mRNA transcripts 24 hours post-injury is consistent both with RIS and the 
requirement for an additional signal for effective regeneration. The dip in axonal 
transcript levels at time points between 1 and 24 hours, as opposed to steadily increasing 
or stably increased levels, also supports the notion of two different mechanisms for 
transcript recruitment to the axon. 
Subsection 2: Specificity and differential regulation of axonal transcript levels: early 
injury response 
A number of transcripts have been shown to alter their axonal levels following 
axotomy of central neurons [21].  As expected, mRNA levels for β-actin, whose local 
synthesis has been extensively characterized, increased after axotomy, serving as a sort of 
positive control. Consistent with RIS signaling, we also observed rapid increases in both 
importin β and RanBP1 transcript levels, but interestingly, not vimentin. Transcriptional 
inhibition also revealed differences in the response of evaluated genes. The early increase 
in axonal levels of RanBP1 and β-actin, like GAP-43, depended on newly synthesized 
mRNAs (Fig 3; [22,146]).  Conversely, importin β, like several other genes, such as 
CGRP, moved into axons [146,147], indicating an additional non-transcriptional 
contribution to axonal synthetic capacity.  
Differential regulation of importin β1 compared to RanBP1 (or vimentin) genes 
may in part be a consequence of the functional diversity of importin β, and thus the 
potential for its recruitment away from other functional roles. In addition to nuclear 
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transport in the cell body, such roles for importin β include quality control of ER proteins 
[138], assembly of mitotic spindles and centrosomes [135,136], and in learning-related 
plasticity in CNS [148].  On the other hand, though, importin isoform localization is 
dictated by its 3’ UTR, with a short 3' UTR variant of importin more prominent in cell 
bodies and a longer variant more prominent in axons [54].  Thus, any pre-existing 
recruitable pool of importin β1 mRNA must be pre-designated for axonal localization.  
Candidates for such a transport-ready pool are ribonucleoprotein particles (RNPs), which 
can migrate to axons and dendrites in response to a given stimulus [149,150]. Such 
activity has been noted in response to a variety of stimuli, for example, axonal transport 
of β-actin mRNA following the application of neurotrophins to chick cortical neurons 
[27,41].   
 
Subsection 3: A role for importin β in regulating axonal levels of mRNAs: delayed injury 
response 
Several lines of evidence suggest that importin β plays an important, even 
essential, role in the response to axonal injury.  In the PNS, importin-associated RIS 
complexes transport signaling proteins, including transcription factors such as JNK, Erk, 
ATF2, and ATF 3, from the injury site [36,55,151], and the depletion of importin β 
results in suppressed gene transcription and delayed functional recovery following nerve 
injury [54].  Importin β also stimulates axotomy-induced axonogenesis in the CNS, in 
part by transporting the transcription factor STAT3 [56,57].  
  Our data support an important role for importin β1 post-injury, and reveal novel 
and intriguing temporal dynamics of an importin-mediated neuronal response. Based on 
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RIS complex transport rates, transcription rates, and mRNA transport rates [68,152], it is 
unlikely that importin β mediated nuclear import plays a role in transcriptional changes at 
1 hr post-axotomy. However, our data suggest that importin β  plays a critical role in the 
secondary wave of axonal transcript elevation upon injury.  Increased importin β1 
expression over 6 hours [Fig. 4c] indicates that early increases in importin β1 transcript 
are translated.  In addition, axonal elevation of importin β1 and RanBP1 transcripts was 
suppressed following specific pharmacological inhibition of nuclear import, with other 
importin functions, including RIS complex formation, presumably intact [Fig 6].  
Together, these data suggest that rapidly synthesized importin β1 feeds back to further 
upregulate the axonal localization RIS associated genes.  
 
Subsection 4: RIS in the CNS versus PNS 
Our work points to interesting similarities and differences between RIS signaling 
in the PNS and CNS. On one hand, we confirm that axonal levels of the RIS-associated 
genes importin β1and RanBP1 indeed increase following central axonal injury, and 
importin β plays a key role in regulating this increase. Our observed increase in axonal 
levels of importin β1 after 6hrs of axotomy [Fig 4a] is similar to that in the PNS, with 
maximum increases observed 6-8 hrs after axotomy [36]. A recent study by Ohara and 
colleagues suggested that, unlike our results, several axonal proteins, including importin 
β1, slightly increased 10 mins after axotomy of dissociated cortical neurons, before 
returning to control levels 1 hr post-injury [57].  However, isolated axons were harvested 
only from regions distal to the injury site, which were presumably degenerating. Axonal 
regions proximal to the injury site in this study were not separated from cell bodies 
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[56,57], precluding direct comparison with our results. Additionally, no further 
quantification was performed beyond 1hr.   
On the other hand, in contrast to studies in the PNS, which show a gradual 
increase in axonal protein levels of vimentin and RanBP1 over period of 6hrs after 
axotomy in the PNS [53,55], we observed neither. In fact, our study, which examined for 
the first time in the CNS axonal protein expression of RanBP1 and vimentin, indicated 
unchanged vimentin transcripts over 24 hours, and, in fact, a reduction in axonal protein 
levels of vimentin within 6 hrs after axotomy [Fig 4e]. While in the PNS, calpain-cleaved 
vimentin binds to phosphorylated ERKs (pErk), linking pErk to dynein via importin β1 
[55], this regulatory pathway does not appear to be conserved in our CNS model. Our 
observed RanBP1 axonal levels also differed from observations in the PNS studies.  It is 
not clear why axonal levels of RanBP1 were reduced at 3 hours post-injury; however, the 
subsequent increase at 6 hrs post-axotomy is consistent with increased transcript levels 
[Fig 2 vs. 4d] and possible inclusion in RIS complexes.  
Section 5: Conclusions 
Our observed novel biphasic increase in axonal gene expression suggests tightly 
and differentially regulated control of local protein synthesis in hippocampal neurons, 
including a key role for importin β-mediated nuclear import [Illustration 1, Table 1]. 
While our focus was on the regulation of RIS associated genes, additional details 
regarding local protein synthesis and RIS signaling in CNS axons, including the exact set 
of transcription factors responsible for de novo mRNA synthesis as well as details 
regarding zip-code-like proteins that regulate axonal mRNA transport for RIS genes, 
remain to be elucidated. Additionally, how such details influence localized protein 
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synthesis and axonal outgrowth must also be elucidated.  Our findings confirm intrinsic 
regenerative capabilities in the CNS, and have important implications for exploiting RIS 
and local protein synthetic pathways towards enhanced CNS 
repair.
 
Illustration 4-1: Schematic presentation of RIS-associated axonal transcript levels post-injury. The 
schematic summarizes the findings of the study. Specifically, injury triggers biphasic elevation in 
axonal transcript levels. At an earlier time point, these levels are differentially regulated; where, 
some require new transcription and others do not. Injury triggers increase in axonal importin β 
protein levels suggesting contribution in formation of RIS-complex. And, at later time point, 




Table 4-1: Summarized Results 
 
Section 6: Methods 
Ethics statement: All animal protocols were approved by University of Maryland 
Institutional Animal Care and Use Committee (IACUC). 
 
Explant culture:  
C57/Black 6 mouse neonates (P1) were euthanized. Brains were harvested and 
maintained in cold Hank's Balanced Salt Solution (HBSS) (HBSS 500 mL, D glucose 
.4g, HEPES .834g, and Penicillin 15 mL).  Curved forceps were used to split the left and 
right hemispheres of the brain, meninges carefully removed, and hippocampus detached 
from surrounding tissue and maintained in ice cold HBSS (2).  For explant culture, the 
hippocampus was placed on a ~0.2 µL drop of Matrigel on lysine (1mg/ml)-coated glass 
cover slips.  An additional 0.2 µL of matrigel was introduced to the underside of the 
explant as needed with a micropipette, to further secure the explant to the substrate. After 
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30 minutes incubation, culture media (Neurobasal media supplemented with 2% B-27) 
was added.  Media was changed carefully every 3 days, so as not to dislodge the explant. 
All cells were maintained at 37°C and 5% CO2. Detached explants or fragmented 
hippocampi were discarded. 
 
Axon Isolation:   
Explants were allowed to grow for seven days, after which axons were severed with a 
needle at a distance ~2/3 of the longest axons away from the explant edge. Injured or 
non-injured axons were collected using appropriate lysis buffer and a micropipette, 
through careful observation under a light microscope.  To avoid any cell body and 
dendritic contamination, we avoided regions at the explant edge. For severed axons, 
tissue was collected both proximal and distal to the injury site, to enable comparison with 
corresponding control axons. We performed additional analysis on each sample to assess 
the exclusive axonal nature of the preparation. For gene expression assays, we confirmed 
the absence of γ–actin mRNA by PCR, which resides only in the soma but is restricted 
from axons [118,119,120].  For protein assays, we confirmed the absence of Neun, a 
neuron-specific nuclear, and thus axon-excluded, protein by immunoblotting [153]. Any 
samples that were contaminated with cell body markers were not used for further 
analysis.  
 
Axonal gene expression: 
Control or uninjured axonal samples were collected at 1, 6, 15, and 24 hours post-injury. 
For detection of axonal transcripts, ~ 100 ng of RNA from axons was used as a template 
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for reverse transcription (RT) with M-MLV Reverse Transcriptase (Invitrogen, Carlsbad, 
CA) and an oligo (dT) primer at 90°C for 1 h. The RT reactions were diluted 10-fold and 
used for transcript specific PCR. For primer sequence, we used Primer 3 tool based on 
specific nucleotide sequence found on PubMed. Primer sequences used for PCR are 
outlined in Table 1. Negative controls were performed on each sample, and consisted of 
RNA processed without the addition of reverse transcriptase. For quantitative RT-PCR, 
the control and sample RT reactions above were amplified using the Thermocycler 
detection system (Bio-Rad, Hercules, CA). These reactions were performed using the Soo 
Fast Green Eva Mix Master Mix (Bio-rad, Hercules, CA) for all transcripts. All control 
and samples were assayed in triplicate for four independent experiments. Thermal cycling 
was initiated with an initial denaturation at 50°C for 2 min and 95°C for 10 min followed 
by 40 cycles at 95°C for 15 s and 60°C for 1 min. Relative levels of individual transcripts 
were calculated by normalizing to the CSF1 control using a comparative threshold value 
(Ct) method. Briefly, the Ct for each transcript was determined using the automatic Ct 
algorithm of the My IQ software to calculate the optimal baseline range and threshold 
values. Individual ΔCt values were then determined by subtracting the CSF1 Ct value 
from the individual transcript Ct values. From this, the calculation of ΔΔCt was 
determined by subtracting the ΔCt Sample (injury to the axons) from ΔCt control (no 
injury to axon) The fold difference was then expressed as 2-ΔΔCt, with ΔΔCt+SD and 
ΔΔCt - SD where SD is the standard deviation attained from Ct values as described in 
Livak et al. [154].  Transcript levels are expressed relative to the ΔΔCt values of the 
control (uninjured) axons. As some transcripts were expressed at very low levels in 





Genes Primers Forward Primers Reverse  
β-Actin ccaccatgtacccaggcatt agggtgtaaaacgcagctca 
γ-Actin cttacactgcgcttcttgcc aatgcctgggtacatggtgg 
Importin β1 gtctctactctgcgcgactc gctaccactccgtccgtatg 
RanBP1 ttaagatgcgtgcaaagctg gcttcagctccatcattggt 





Data were compared statistically using relative expression software tool (REST©, 
Qiagen, Valencia, CA), as described in the study of Pfaffl et al [155]. Type I error α was 
set to 0.05.  
 
Actinomycin d-treatment:  
Actinomysin-d (AMD) dose was set at 5 µg/ml [156], and  treatment duration was varied 
from 1 to 3 hrs to test transcriptional inhibition in explants. As AMD treatment resulted 
in inhibition of transcription within two hours, explants were treated with this dose for 
two hours before being injured (or not, for controls). Samples were collected one hour 
post-injury and RT-PCR was performed as above, with AMD treated uninjured axons 




Inhibiting Nuclear Transport: 
Importazole (IPZ; Sigma-Aldrich, St. Louis, MO) has been well characterized in non-
neuronal cells [139]. We have followed a similar approach to characterize inhibition of 
importin-mediated nuclear import in our system. Explants were transfected 12 hrs prior to 
IPZ treatment with NFAT-GFP expression plasmid (pKW520, a kind gift from Dr. 
Karsten Weis), using Effectene transfection reagent (Qiagen, Valencia, CA) per 
manufacturer’s instructions.  All transfections took place in Neurobasal supplemented 
with 2% B-27 (Life Technologies).  
IPZ was used at concentrations of 18 µM for up to 24 hours, supplying fresh media with 
IPZ every 12 hours. For controls, fresh media without IPZ was used. At 22 hours (1.5 
hours prior to 24 hours treatment), ionomycin was added at 15 µM to induce intracellular 
calcium influx and trigger nuclear import. To assess import, cells were fixed with 4% 
formaldehyde prior to fluorescence microscopy. DNA was visualized with 1 µg/ml 
Hoechst dye. For quantification, 100-200 cells for each condition were analyzed and 
nuclear accumulation of NFAT-GFP was assessed using Image J. 
 
Cell viability: 
To test cell viability, after transfection, IPZ and Ionomycin treatments, cultures were 
washed three times and assessed using Live/Dead reagent (Invitrogen, Grand Island, 
NY), per manufacturer's protocol. Explants were incubated for 20 minutes, washed, and 
imaged via an inverted Nikon TE-2000E microscope.  Cell viability of explants 




Immunofluorescence and imaging: 
Hippocampal explants were fixed with 4% paraformaldehyde in PBS for 10 minutes and 
rinsed with PBS three times. Following permeabilization with 0.2% Triton X-100 in PBS, 
the cells were blocked with 10% Fetal goat serum and 3 % BSA for 30 minutes.  1:1000 
dilution of SMI-31 (Abcam Inc., Cambridge, MA) and/or 1:500 dilution of MAP2 
(Abcam Inc., Cambridge, MA) in BSA was applied for 1 hour at room temperature, 
followed by three washes in PBS.  Fluorescently labeled secondary antibody was applied 
subsequently for 1 hr at 37°C, followed again by three washes in PBS.  Explants were 
imaged using a Leica SP5X confocal microscope. 
 
Immunoblotting: 
After 1, 3, 6 hours of injury, control (uninjured) axons, and positive control (whole 
explant) samples were lysed using NP40 lysis buffer mixed with protease inhibitor 
(Fisher-Scientific, Houston, TX) and phosphatase inhibitor (Roche Diagnostics, 
Indianapolis, IN, USA). The homogenate was further lysed in liquid nitrogen, and 
supernatant was stored at -80ºC.  Protein concentration was measured using a 
bicinchoninic acid (BCA) protein assay kit (Pierce; Thermo Fisher Scientific, Rockford, 
IL, USA). An equal amount of the protein (60 µg) was loaded into each lane, run on 4- 
15% Mini-Protean Precast gel (Bio-rad, Hercules, CA), and transferred to PVDF 
membranes (Millipore, Billerica, MA). The membranes were blocked overnight using 
casein-blocking buffer (Vector Lab, Burlingame, CA), and incubated for 2 h at RT either 
with RanBP1 antibody (diluted 1 : 100; Santa Cruz, Dallas, TX) or vimentin antibody 
(diluted 1 : 100; Abcam, Cambridge, MA). Alternately, membranes were incubated for 
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35 minutes at RT with Importin β1 antibody (diluted 1:300, Abcam, Cambridge, MA), 
GAPDH (diluted 1:60000, Fitzgerald, Acton, MA ) or, Neun (diluted 1:500, Millipore, 
Billerica, MA).  Appropriate secondary antibodies, and DuoLux Chemiluminescent was 
used for detection following protocol given in Vectastain-AMC Amp kit (Vector Lab, 
Burlingame, CA). The membranes were detected using ChemiDoc™ XRS+ (Bio-rad, 
Hercules, CA), and analyzed using Image Lab software (Bio-rad, Hercules, CA). All data 
were normalized to GAPDH. 
 
Fluorescence Microscopy: 
Imaging was performed on an inverted TE-2000E microscope (Nikon, Melville, NY) 
outfitted with a Lumen-PRO2000 (Prior Scientific, Rockland, MA) illumination system 
and Chroma filters (Bellows Falls, VT. EPI: 488 nm, Emission 530 nm). Additionally, a 
custom built chamber (Precision Plastics, Beltsville, MD) maintained temperature, 
humidity, and CO2 levels during imaging. Additionally, Leica SP5X confocal 
microscope (Buffalo Grove, IL) was used for explant imaging and importazole treated 
sample imaging.  The confocal system is equipped with multiple laser lines, including a 
405 diode, an Argon laser (458, 476, 488, 496,514nm) and a white light laser (470-
670nm in 1 nm increments); they were either imaged using a 10x or 40x objective with 
Hoechst (Excitation 350 nm, Emission 451 nm), SMI-31 (Excitation 579nm, Emission 
599 nm), and Map2 (490 nm, Emission 530 nm) markers.  
 
Statistics and Sample Sizes: 
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All the PCR experiments were assayed in triplicate for three-four independent 
experiments.  Specifically, axonal injury experiments N=3 for 1 and 24 hrs, and N=4 for 
6 and 15 hrs time points. Both the AMD and IPZ treated samples size were N =3, except 
for Ranb1, in which only a single sample amplified this transcript, possibly due to IPZ 
effects on both control and injured populations, unrelated to injury response. Data were 
compared statistically using relative expression software tool (REST©, Qiagen, Valencia, 
CA), as described in the study of Pfaffl et al. For Importazole characterization, 100-200 
cells were quantified from two different explants for each condition, control, IPZ 
treatment for 12 hrs and 24 hrs.  One-way student's t-test was used for statistical analysis.  
For immunoblots, the following sample sizes were used: Importin β1: N=5, RanBP1: 
N=3, and vimentin: N =4. Values presented illustrate as percent of control.  One-way 
student's t-test was used for statistical analysis.  For all experiments, type I error α was set 




Chapter 5:  Conclusion 
Section 1: Introduction 
Unlike PNS neurons, neurons of the CNS do not possess the ability to regenerate after 
axonal injury.  This less effective regeneration capability leads to many chronic CNS 
functional deficits following spinal cord and brain injury or degeneration.  Development 
of regeneration strategies will be applicable to many CNS disorders, such as spinal cord 
injury (SCI), genetic disorders such as mental retardation, aphasia, and degenerative 
diseases such as Alzheimer's disease.  One regeneration approach is to understand and 
exploit the intrinsic growth capacity of neurons. One such intrinsic mechanism post 
axotomy is localized protein synthesis (LPS).  It is a well-established phenomenon that 
LPS is required for axonal regeneration.  Among its several associated processes, LPS 
requires gene transcription, which has been proposed as a major controlling mechanism 
for axon growth and after injury [31].  Between PNS and CNS, major gaps exist on this 
subject, specifically in the context of changes in the localization of mRNA transcripts 
required for LPS, and injury induced retrograde injury signaling.  Importantly, both 
defects in mRNA transport and RIS mechanisms have been linked to impaired 
regenerative ability of neurons [46,47]. Thus, our study set out to explore two of these 
regeneration pertinent mechanisms in local protein synthesis: 
• The detailed quantification of mRNA transport during hippocampal neuron 
development (Chapter 2). 
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• Regulation of recruitment of retrograde injury signaling complex-related genes in 
central axons following injury (Chapter 4), using a mouse whole hippocampal 
explants culture system (Chapter 3).  
Section 2: Findings and Implications 
The main findings are chapter specific and were summarized with the respective 
chapters: A comparative quantitative assessment of axonal and dendritic mRNA transport 
in maturing hippocampal neurons (Chapter 2), a mouse whole hippocampal explant 
culture system to study isolated axons (Chapter 3), and biphasic increase of retrograde 
injury signaling complex-related genes in central axons following injury (Chapter 4). 
 
Subsection 1: A comparative quantitative assessment of axonal and dendritic 
mRNA transport in maturing hippocampal neurons 
We have identified unique mRNA transport profiles both in the axons and 
dendrites at varying stages of neurite maturity. Specifically, neurons at day 4 with a free 
terminal were designated as immature (growing), differentiated neurons. Neurons at days 
7 and 12 were both designated as differentiated neurons with stable synapses, with those 
at day 12 presumably more mature.  Surprisingly, we were able to find two different 
pools of mRNA populations that were labeled dimly (faster velocities), and brightly 
(slower velocities). The bright and dim velocities in axons peaked at day 7. The increase 
in net axonal velocity coincides with the end stages of neurite outgrowth and the initial 
stages of synapse formation and stabilization.  This indicates significance of local 
translation contributing to synapse stabilization pre-synaptically.  This timeline also 
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parallels the relationship between local translation and the effectiveness of neurotrophic 
signaling during axonal outgrowth and pre-synaptic signaling.  Specifically, BDNF and 
NT-3 neurotrophins play an important role in effective axonal guidance [4,86].  Net 
dendritic velocities of bright mRNA particles were linear with highest velocities at day 
12. The increase in mRNA transport at later time points in dendrites is consistent with its 
role for local protein synthesis in the context of sustained synaptic connectivity for long-
term potentiation (LTP) [4,17,61,86,87,89].  Proteins relevant for synaptic plasticity are 
observed in dendritic mRNA pools; these include αCAMKII [91] and cytoplasmic 
polyadenylation element binding protein (CPEB).  
 
Several studies have indicated that adult CNS neurons lose their regenerative 
capabilities, whereas embryonic neurons possess the ability to regenerate [31,157]. Since 
then the focus has been to investigate axonal growth during development and axon 
regeneration and to examine the factors that could promote axon regeneration in the adult 
CNS.  Here, we have identified mRNA transport profiles in hippocampal neurons as they 
develop in vitro, with hope to recapitulate the developmental pathway during axonal 
regeneration.  The next step in this direction would be to identify how the transport 
profiles change during axonal regeneration.  The difference between the development and 
regeneration profiles could be beneficial in identifying key factors that influence CNS 
regeneration.  Additionally, since genetic transcription is imperative in controlling the 
intrinsic axon growth/regeneration, it would be beneficial to focus on regulation of 
specific mRNAs before and after injury.  Using this logic, the next step in our project was 
to understand the regulatory mechanism of RIS associated genes in the axons. Because 
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the study required axonal genetic and protein analysis independent of contamination by 
the cell body, we developed a novel explant culture system to enable axonal-specific 
characterization. 
Subsection 2: Mouse whole hippocampal explant culture system to study isolated 
axons 
Here, we developed a simple and feasible whole-hippocampal explant culture 
system to study central neuronal survival and axonal gene and protein expression in the 
context of regeneration. The explant culture system enabled axon-specific measurements 
without the need of additional equipment.  In this report, we detailed our validation of 
this model, and its implementation to characterize axonal outgrowth following initial 
explant harvest and a secondary axonal injury.  This model will be useful in probing 
mechanistic questions in central axons. The simplicity will be beneficial in enabling 
genetic and pharmacological manipulation to answer neural injury and regeneration 
questions.  We have ourselves utilized the system to understand the underlying 
mechanisms involved in RIS, a key process underlying for axonal regeneration.   
Subsection 3: Biphasic increase of retrograde injury signaling complex-related 
genes in central axons following injury 
Our results suggests biphasic axonal response, in which levels of several axonal 
transcripts, including those associated with RIS, increase rapidly in axons after injury, 
contributing to early synthesis of corresponding proteins. Importin β-dependent activity 
at the nucleus then appears to modulate a second wave of RIS-associated transcripts, 
which are likely to further support axonal outgrowth.  Additionally, these transcripts are 
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regulated differently where a first wave is probably regulated via an initial early response, 
and later response is regulated as a feedback mechanism of importin β-mediated RIS 
pathway itself.   
RIS has implications for axonal regeneration in the PNS and CNS. [56].  
According to our results, both mRNA and protein localization in axons are highly 
regulated. We believe that altering/controlling these regulatory pathways could be 
beneficial in promoting regeneration.   
Section 3: Future Experiments and Clinical Significance 
Immediate next steps: The identification of the specific signals that are 
transported from distant injury sites and the mechanism of such transport should provide 
critical insight into the development of novel therapies to promote neuronal regeneration 
and functional recovery. The immediate next step in this direction would be to further 
unveil this mechanism.  One of the initial experiments could be to understand what 
causes the initial changes (~1hr) in mRNA localization post-injury, for example, cascades 
of calcium-mediated transcriptional or translational regulation in the cell body.  Then, we 
could develop strategies to trigger mRNA changes and localized protein synthesis by 
manipulating genes or proteins involved in these pathways to improve axonal 
regeneration.  We can also investigate what triggers the differential mRNA response at 
1hr post-injury, or what specific cargo is directly responsible for mRNA transcript 
changes (~24hrs). For example, if STAT3 plays an important role, we could then 
manipulate STAT3 or other RIS associated signaling molecules genetically or 
pharmacologically, to observe if mRNA transcripts are altered.   
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Longer-term studies: Defects in retrograde signaling may underlie the 
pathophysiological basis of several neurodegenerative diseases.  As PNS neurons are able 
to regenerate compared to CNS neurons, knowing the similarities and differences 
between the two systems will be beneficial in overcoming the inability of CNS neurons to 
regenerate.  Further, our initial studies were all in vitro, allowing us to manipulate the 
experimental system.  However, whether RIS occurs and has a role in recovery after 
central nervous system injury, such as traumatic brain injury and spinal cord injury is 
unknown in vivo.  The next challenge will be to explore mechanisms of RIS in vivo, and 
manipulate RIS pathways in order to promote regeneration. 
Our overall goal of the project is to understand the underlying key processes 
involved in axonal regeneration in order to treat brain injuries.  It will be beneficial to 
consider combining approaches to block extrinsic inhibition while enhancing the intrinsic 
growth program of the neurons.   
The purpose of the thesis is to provide one step forward in promoting axonal 
regeneration.  We hope that the findings will be beneficial in unveiling many regenerative 
processes both in the CNS and PNS, and eventually lead to therapies promoting axonal 
regeneration. 
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Section 1: Chapter 2 Supplementary Tables 
Table S1: Summary of maximum velocities for various classes of labeled cargoes. * 
Significant difference (day 4 vs. day 12 *p<.05).  Significant difference (p<.05). 
Significant difference (day 7 vs. day 12 p<.05). 
Average Maximum Velocity Day 4 Day 7 Day 12 
mRNA Axon anterograde (Dim) 0.08± .02 0.09±.01 0.11±.01 
mRNA Axon retrograde (Dim) -0.04±.01 -0.04±.007 -0.05±.01 
mRNA Dendrite anterograde (Dim) 0.13±.03 0.12±.02 0.2±.03 
mRNA Dendrite retrograde (Dim) -0.05±.02 -0.04±.009 -0.07±.05 
mRNA Axon anterograde (Bright) 0.01±.003 0.02±.004 0.007±.003 
mRNA Axon retrograde (Bright) -0.004±.0009 -0.006±.001 -0.008±.002 
mRNA Dendrite anterograde (Bright) 0.008±.004 0.02±.005 0.008±.003 
mRNA Dendrite retrograde (Bright) -0.02±.009[*] -0.01±.003 -0.005±.001[*] 
Mitochondria Axon anterograde 0.008±.001 0.01±.002 0.008±.002 
Mitochondria Axon retrograde -0.009±.002 -0.008±.002 -0.007±.001 
Mitochondria Dendrite anterograde 0.002±.0008 0.007±.003 0.004±.0007 











Table S2: Summary of average velocities for various classes of labeled cargoes. * 
Significant difference (day 4 vs. day 12 p<.05). Significant difference (day vs. day 7 p< 
.05). Significant difference (day 7 vs. day 12 p<.05). 
Average Velocity Day 4 Day 7 Day 12 
mRNA Axon anterograde (Dim) .06±.02 0.08±.02 0.08±.02 
mRNA Axon retrograde (Dim) -0.03±.01 -0.03±.01 0.03±.01 
mRNA Dendrite anterograde (Dim) 0.1±.02 0.08±.009 0.12±.009 
mRNA Dendrite retrograde (Dim) -0.03±.01 -0.03±.007 -0.06±.03 
mRNA Axon anterograde (Bright) 0.005±.001 0.009±.001 0.004±.001 
mRNA Axon retrograde (Bright) -0.003±.0004 -0.004±.0005 -0.004±.0009 
mRNA Dendrite anterograde (Bright) 0.004±.003 0.01±.008 0.007±.002 







Mitochondria Axon anterograde 0.003±.0005 0.004±.0009 0.004±.0005 
Mitochondria Axon retrograde -0.006±.002 -0.004±.0009 -0.003±.0005 
Mitochondria Dendrite anterograde 0.001±.0003[] 0.005±.002[] 0.002±.0003 








Table S3: Summary of duration spent moving in each direction for various classes of 
labeled cargoes. * Significant difference (day 4 vs. day 12 p<.05).  Significant 
difference (day 4 vs. day 7p<.05). Significant difference (day 7 vs. day 12 p<.05).   
Particle Duration Day 4 Day 7 Day 12 
mRNA Axon anterograde (Dim) 144 ±34[] 143±17[] 179±19 
mRNA Axon retrograde (Dim) 84±20 100±16 83±15 
mRNA Dendrite anterograde (Dim) 110±21 200±22 168±18 
mRNA Dendrite retrograde (Dim) 67±23 61±14 27±18 
mRNA Axon anterograde (Bright) 297±34 234±26[] 330±24[] 
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mRNA Axon retrograde (Bright) 363±40 300±34 311±36 
mRNA Dendrite anterograde (Bright) 225±50 281±32 320±31 
mRNA Dendrite retrograde (Bright) 294±86 278±71 331±56 
Mitochondria Axon anterograde 472±36[*] 473±37[] 255±26[*][] 
Mitochondria Axon retrograde 308±33[*] 260±33[] 517±31[*][] 
Mitochondria Dendrite anterograde 264±50[*] 342±42 449±47[*] 











Table S4: Summary of net velocities for various classes of labeled cargoes. * Significant 
difference (day 4 vs. day 12 p<.05).  Significant difference (day 4 vs. day 7p<.05).  




Net Average Velocity Day 4 Day 7 Day 12 
mRNA Axon (Dim) 0.03±.02 0.04±.01 0.04±.01 
mRNA Dendrite (Dim) 0.0705±.03 0.05±.02 0.1±.02 
mRNA Axon (Bright) 0.0002±.0003 0.002±.001 0.0001±.0004 
mRNA Dendrite (Bright) -0.003±.001[*] -0.0001±.002 0.001±.0006[*] 
Mitochondria Axon -0.0002±.0002 -0.0004±.0007 0.0006±.0003 
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